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INTRODUCTION 
 
CHAPTER I. Panic Disorder: definition, 
epidemiology, etiology, treatments, clinical 
research and PD theories 
 
 
1) Definition and epidemiology of Panic 
Disorder  
 
Panic disorder (PD) is a heterogeneous psychiatric 
syndrome that affects 3-5 % of the population. The DSM-
V  includes panic disorder in the anxiety disorders (DSM-
V 2013). Recurrent panic attacks (PAs) are the hallmark 
feature of diagnosis panic disorder. Individuals with this 
disorder experience recurrent panic attacks and are 
persistently concerned or worried about having more 
panic attacks or change his/her behavior in maladaptive 
ways because of the PAs. Panic attacks are abrupt surges 
of intense fear or intense discomfort, that reach a peak 
within ∼10 minutes; can occur in calm or in anxious state 
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and are accompanied by physical (incapacitating periods 
of acute-onset respiratory, cardiovascular, 
gastrointestinal, autonomic) and/or cognitive symptoms. 
To diagnose panic disorder in addition to PAs four or 
more of following symptoms occur:  
1. Palpitations, pounding heart, or accelerated heart rate; 
2. Sweating; 
3. Trembling or shaking; 
4. Sensations of shortness of breath or smothering; 
5. Feelings of choking; 
6. Chest pain or discomfort; 
7. Nausea or abdominal distress; 
8. Feeling dizzy, unsteady, light-headed, or faint; 
9. Chills or heat sensations; 
10. Paresthesia (numbness or tingling sensations); 
11. De-realization (feelings of unreality) or 
depersonalization (being detached from oneself); 
12. Fear of losing control or “going crazy”; 
13. Fear of dying. 
Another criterion to diagnose PD is that at least one of 
the attacks has been followed by 1 month (or more) of 
one or both of the following: 
1. Persistent concern or worry about additional panic 
attacks or their consequences 
2. A significant maladaptive change in behavior related to 
the attacks  
The recurrent PAs are categorized in the DSM-V as being 
either unexpected (also called spontaneous) (uPA), or 
expected (ePA). The uPAs occur in the absence of a clear 
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external trigger whereas ePAs occur where an external 
cue (e.g., situation where uPAs have occurred, or when 
confronted with a generally feared phobic situation or 
stimulus) is associated with the induction of the PA 
(Shulman et al. 1994). Collectively, recurrent PAs can lead 
to agoraphobia, which is a conditioned avoidance 
response that occurs when people with PD begin to fear 
situations that are associated with PA or where escape 
might be difficult or help might not be available (e.g., 
planes, elevators etc.) if a PA were to occur.  
Already in 1993 Briggs and colleagues identified two 
subtypes of PD based on the presence or 
absence of prominent respiratory symptoms (Briggs, 
Stretch, and Brandon 1993). Studies demonstrated that 
the respiratory subtype patients feel a stronger 
suffocation  and have more panic attacks than the non-
respiratory subtype patients during the carbon dioxide 
challenge tests (Biber and Alkin 1999; Valenca et al. 
2002; Abrams, Rassovsky, and Kushner 2006). In addition 
in this group there is a higher family history of panic 
disorder, less comorbidity with depression, a longer 
duration of panic disorder, lower scores on the scale of 
neuroticism and, in general, higher scores on scales of 
severity for panic disorder. These subjects are 
particularly sensitive to methods of artificial induction of 
panic. From the respiratory point of view there is a 
greater sensitivity to the panicogenic effects of CO2 
(Freire et al. 2008). 
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Epidemiology. Anxiety disorders are a heterogeneous 
classification that has a lifetime prevalence of about 20% 
in the general population. Panic Disorder represents one 
of the most severe anxiety disorders and current 
estimates are that about 7–10% of the population 
experience occasional PAs and the prevalence of PD in 
the general population is ∼2–5% (Goodwin et al. 2005; 
Kessler et al. 2006). 
Lifetime prevalence estimates are 22.7% for isolated 
panic attacks only, 0.8% for PA with agoraphobia without 
PD (PA-AG), 3.7% for PD without AG (PD-only), and 1.1% 
for PD with AG (PD-AG). Persistence, number of lifetime 
attacks, and number of years with attacks all increase 
monotonically across these four subgroups (Kessler et al. 
2006). 
The age of the onset for panic disorder varies 
considerably with the median age which ranks among 20-
24 years in United States population. A small number of 
cases begin in childhood, and onset after age 45 years is 
unusual but can occur. The rates of panic disorder show a 
gradual increase during adolescence, particularly in 
women, and possibly following the onset of puberty, and 
peak during adulthood (DSM-V 2013). Women are more 
frequently affected than men, at a rate of approximately 
2:1. The gender differentiation occurs in adolescence and 
is already observable before age 14 years (Kessler et al. 
2006; Sheikh, Leskin, and Klein 2002; DSM-V 2013). 
Although panic disorder is very rare in childhood, first 
occurrence of "fearful spells" is often dated 
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retrospectively back to childhood. As in adults, panic 
disorder in adolescents tends to have a chronic course 
and is frequently comorbid with other anxiety disorders 
(in particular with agoraphobia), depressive, and bipolar 
disorders and possibly mild alcohol use disorder. A 
subset of individuals with panic disorder develops a 
substance-related disorder, which for some represents 
an attempt to treat their anxiety with alcohol or 
medications. Comorbidity with other anxiety disorders 
and illness anxiety disorder is also common especially in 
individuals with more severe agoraphobia (Social phobia 
it has been referred in 15%-30% of PD individuals; the 
obsessive-compulsive disorder in 8%-10% of them and 
generalize anxiety disorder in 25% of them). The 
separation anxiety disorder (SAD) during childhood 
resulted associated with panic disorder (DSM-V 2013). 
 
 
2) Etiology of Panic Disorder  
 
Although the etiology of PD is largely unknown, several 
studies demonstrated that there is a strong heritability in 
first degree relatives (∼11%) and monozygotic twins (30–
40%) [see meta-analysis and reviews by (J M Hettema, 
Neale, and Kendler 2001; Schumacher et al. 2011)]. This 
heritability was already been referred in first studies in 
which panic disorder was called anxiety neurosis (COHEN 
et al. 1951). 
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Additional data have shown a higher risk of panic 
disorder in adult first-degree relatives when the age of 
onset was less than 20 years (Goldstein et al. 1997). 
However, the major basis of genetic contribution to 
anxiety disorders is provided by the higher concordance 
rates for monozygotic twins compared with dizygotic 
twins (Marco Battaglia et al. 2009; Bellodi et al. 1998; G 
Perna et al. 1997; Torgersen 1983). The use of the two 
biggest databases of twins’ information, the “Virginia 
Adult Twin Study of Psychiatric and Substance Use 
Disorder” (VATSPSUD) and the “Vietnam Era Twin” (VAT), 
permitted to observe a variance of panic disorder 
heritability due to a genetic factor for 30%-40%, being 
the rest of the variance because of individual-specific 
environment, with an estimated heritability of 44% (K S 
Kendler, Gardner, and Prescott 2001; G Perna et al. 
1997). 
Many genetic studies have tried to identify linkage or 
association to clarify molecular basis of genetic factors in 
panic disorder [ for a review see (Gratacòs et al. 2007)]. 
Linkage studies permit to indicate approximatively a 
chromosome region of one gene or genes associated 
with a defined phenotype. On the other hand in the 
associative studies the association between a specific 
DNA sequence and the disease is analyzed in a sample of 
subjects.  
Total genome scans, in the case of panic disorder, have 
yielded some interesting chromosomal regions, including 
7p15 (Crowe et al. 2001; Logue et al. 2003; Knowles et al. 
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1998), 13q32 (Hamilton et al. 2003; Weissman et al. 
2000) 1q32, 11p15 (Gelernter et al. 2001) and 9q31 
(Thorgeirsson et al. 2003). Recently, one study found that 
one region on chromosome 4q31-q34 shows strong 
evidence of linkage (Kaabi et al. 2006). Also, in a recent 
study, evidence for linkage reached genome-wide 
significance in one region on chromosome 15q (near 
GABA-A receptor subunit genes) and was suggestive at 
loci on 2p, 2q and 9p (A. J. Fyer et al. 2006) 
chromosomes.  
In the review of Gratacòs is reported a table presenting  a 
list of several genes probably involved in genesis of panic 
disorder (Gratacòs et al. 2007). Most of all are genes for 
neurotransmitters, receptors or enzymes involved in 
neurotransmitters’ catabolism or synthesis, and have 
been considered basing on pharmacological or clinical 
evidences (Furukawa, Watanabe, and Churchill 2007; 
Watanabe, Churchill, and Furukawa 2009). Among the 
drugs with clear panicolytic properties, selective 
serotonin reuptake inhibitors (SSRIs) such as fluoxetine, 
sertraline or paroxetine, or venalfaxine, a selective 
serotonin-norepinephrine reuptake inhibitor, have been 
extensively used. Among the panicogenic agents, drugs 
increasing the synaptic availability of noradrenaline, such 
as yohimbine or caffeine, or acting on the adenosine or 
CCKergic systems are used as provoking agents in 
diagnostic explorations. This is in line with clinical 
investigations that have shown abnormal NAergic, 
serotoninergic or GABAergic systems regulation in 
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patients with panic disorder and during panic attacks 
(Balaban and Thayer; Bremner et al. 1996; Goddard, 
Brouette, et al. 2001). Thus, many genetic studies have 
been directed to explore the elements of the 
serotonergic, NAergic, GABAergic or CCKergic systems.  
However more recently, Maron and colleagues 
conducted a meta-analysis of the use of linkage and 
candidate genes in association studies, which founded 
over 1000 polymorphisms and 350 candidate genes, for 
their association with PD (E Maron, Hettema, and Shlik 
2010).  
Although there are several promising, replicable 
candidate genes, most studies produced inconsistent 
results.  
Therefore, even though there is a strong genetic 
predisposition for PD in monozygotic twins and first 
degree relatives, the specific genes associated with PD 
and recurrent PAs may be more heterogeneous than the 
symptoms associated with PAs, and there is most likely 
multiple gene polymorphisms that may contribute small 
but cumulative risks for the symptoms and presentation 
of PD.  
 
Although the importance of genetic factors in the 
etiology of panic disorder, the non-complete 
concordance between monozygotic twins and the studies 
about families have clearly indicated that the genetics is 
not the only factor able to completely determine the 
susceptibility to develop panic disorder. Thus, a growing 
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number of studies investigated how early-life adversities 
add their effects to, or interact with (figure 1), genetic 
risk factors to affect behavior (Rutter, Moffitt, and Caspi). 
Extensive research has been devoted to the identification 
of elements that may act as risk factors and/or 
precipitants of internalizing conditions, and to 
characterize the clinical precursors of anxiety and 
depressive disorders (Kenneth S Kendler, Kuhn, and 
Prescott 2004; Kenneth S Kendler et al. 2003; Faravelli et 
al. 2007; G. A. Fava et al. 1981). Different types of 
adverse events seem to affect the individual 
susceptibility to develop anxiety disorders – including 
panic disorder (PD). Heterogeneous adverse events, such 
as physical illnesses, changes in social activities, loss of – 
or threatened separation from – a loved one, appear to 
play a role in affecting the individual susceptibility to 
panic attacks (Manfro et al. 1996; Horesh et al. 1997). 
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Figure 1: Pathogenic factors in panic disorder. Panic disorder 
is distinct from other forms of anxiety disorders, such as GAD, 
mainly based on pharmacological dissection and more recently 
on twin studies that have shown a, at least partially, 
independent structure of genetic and environmental risk 
factors. Gratacòs et al 2007 
 
Regarding the early physical adverse event, in 1997 
Bouwer and Stein have proposed the hypothesis of the 
traumatic suffocation events, basing on the CO2 ability to 
provoke a panic attack. In their studies the frequency of 
traumatic suffocation was significantly higher among the 
panic disorder patients (19.3%) than among the 
comparison subjects (6.7%). Within the panic disorder 
group, patients with a history of traumatic suffocation 
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were significantly more likely to exhibit predominantly 
respiratory symptoms and nocturnal panic attacks being 
part of respiratory subtype of PD (Briggs et al. 1993). By 
contrast patients without such a history of traumatic 
suffocation were significantly more likely to have 
predominantly cardiovascular symptoms, 
occulovestibular symptoms, and agoraphobia (Bouwer 
and Stein 1997). 
          Another series of studies investigated the impact of 
several early traumatic events such as loss of parents, 
separation by them or abuse events, on the development 
of mental illness including panic disorder. These studies 
pulled out much evidence that these types of early 
adverse events make it more likely the onset of panic 
disorder (Breier, Charney, and Heninger 1986; Fierman et 
al. 1993; Noyes et al. 1993; Servant and Parquet 1994; 
Friedman et al. 2002; Ogliari et al. 2010; Branchi and 
Cirulli 2014). There are many researches that indicate a 
relationship between the separation anxiety disorder and 
panic disorder and will be described in detail in the 
chapter concerning the theories about panic disorder 
(chapter 2). 
          Another informative clue to PD etiology is the age 
of onset, which has a mean age range at diagnosis from 
22 to 23 years in US population (DSM-V 2013), but the 
incidence of PAs and PD show a gradual increase during 
adolescence (Reed and Wittchen 1998) that coincides 
with sex hormone surges and sexual maturation that 
begins at ∼10–12 and ends at ∼15–17 years of age [see 
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review (Kessler et al. 2010)]. This developmental stage is 
accompanied by critical cortical growth and remodeling 
which begins in pre-adolescence and continues to 
develop until early adult- hood when PAs and PD 
typically get diagnosed. Of particular relevance to 
anxiety, fear, and panic states, there is also evidence that 
this is a critical period for development of connectivity of 
the prefrontal cortex with the amygdala and brain stem 
centers (Gee et al. 2012; Gee, Humphreys, et al. 2013; 
Gee, Gabard-Durnam, et al. 2013), all structures that are 
critical for developing fear and panic, and heavily 
implicated in anxiety disorders such as PTSD and PD. This 
connectivity with the prefrontal cortex appears to be 
critical for extinction of fear memories and preventing 
over-generalization of threatening cues (Kheirbek et al. 
2012). Another striking feature of PD is that, compared 
to men, women show earlier age of onset and is twice as 
males to develop PD (Reed and Wittchen 1998; Sheikh, 
Leskin, and Klein 2002). The initiation of fluctuating sex 
steroid hormones over the menstrual cycle in women 
[see review (Nillni, Toufexis, and Rohan 2011)] could be 
an important factor that contributes to the higher rates 
of PA and PD in women, but other factors such as early 
life stress or higher incidence of trauma such as sexual 
abuse or domestic violence in women could also account 
for this vulnerability.  
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3) Treatments for Panic Disorder 
 
A number of neurochemical hypotheses are also 
proposed for the etiology of panic disorder, primarily 
based on the pharmacological therapies that work in 
treating PAs and PD. For example, symptoms associated 
with PAs in PD, and laboratory-induced PAs can be 
rapidly treated with benzodiazepines (Charney and 
Heninger 1985; Tesar and Rosenbaum 1986; Ballenger et 
al. 1988) which effectively enhance inhibitory GABAergic 
tone. Panic attacks associated with PD can also be 
treated with slower-acting pharmacological therapies 
that enhance monoaminergic (e.g., serotonin, 
norepinephrine, epinephrine, dopamine, and histamine) 
activity globally [using tricyclic antidepressants (Rifkin et 
al. 1981) or monoamine oxidase inhibitors (MAOI) (Kelly, 
Mitchell-Heggs, and Sherman 1971)] or by specifically 
targeting serotonergic or noradrenergic systems with 
reuptake inhibitors [see review (Cloos and Ferreira 
2009)]. 
          Most evidence suggests that there is reduced 
inhibitory GABAergic tone in patients with Panic 
Disorder: for example PD patients have reduced GABAA 
receptor binding in frontal cortex (Nikolaus et al. 2010), 
or deficits in central GABA concentration (Goddard, 
Mason, et al. 2001). In addition the GAD1 gene that 
codifies for the enzyme responsible for GABA synthesis 
has been shown to be associated with PD (John M 
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Hettema et al. 2005). For these reasons benzodiazepines 
which enhance GABA activity are effective at treating 
panic symptoms (Nutt et al. 2002; Borwin Bandelow et al. 
2008; Baldwin 2005; Cloos and Ferreira 2009) and 
represent a fast-acting panicolytic treatment; however, 
routine usage makes these drugs less effective due to 
desensitization, and there are many side effects and 
safety concerns such as sedation. 
          First evidence for involvement of serotonin and 
noradrenergic involvement in anxiety and PD pathology 
was due to the effectiveness of tricyclic antidepressants 
(TCA), such as imipramine and clonipramine, for 
managing symptoms in these disorders [see meta-
analyses (Bakker, van Balkom, and Spinhoven 2002; 
Giampaolo Perna, Guerriero, and Caldirola 2011)]. 
Although TCAs have pharmacological actions at many 
receptors, they primarily act as serotonin and 
norepinephrine reuptake inhibitors at the serotonin and 
norepinephrine transporters (5-HTT, and NET, 
respectively) with low affinity for dopamine transporters, 
which increases synaptic concentration of the 
neurotransmitters to enhance neurotransmission. Other 
lines of evidence came from pharmacological inhibition 
of monoamine catabolism using monoamine oxidase 
inhibitors (MAOIs) such as phenelzine for the treatment 
of PAs and PD, but this is considered a third- or fourth-
line approach since it requires a tyramine-restricted diet, 
and can produce serious side effects such as 
hypertensive crisis. Selective serotonin reuptake 
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inhibitors (SSRIs) and norepinephrine reuptake inhibitors 
(SNRIs) are also effective treatments for PAs and PD, and 
the safety and efficacy of these compounds will be 
discussed in the subsequent sections. It is important to 
note that unlike benzodiazepines, these are not fast-
acting panicolytic compounds. In some cases, TCAs (and 
also SSRIs and NRIs) increase anxiety initially, and begin 
to show anxiolytic and panicolytic properties after 2–3 
weeks of daily treatments. Thus, the mechanisms by 
which these compounds are panicolytic are through 
compensatory changes that occur with repeated use, and 
a therapeutic option is to initially co-administer a low 
dose of a benzodiazepine with SSRIs to PD patients, 
which has been shown to result in a 41% response rate, 
compared to 4% response rate for placebo + SSRI group 
in the first week of treatment (Goddard, Brouette, et al. 
2001). Currently SSRIs and NRIs represent the first-line 
treatment for PAs and PD due to their similar efficacy in 
treating PAs (M. H. Pollack et al. 2007; M. Pollack et al. 
2007), with some evidence that SSRIs are more tolerable 
and safe. There are several FDA-approved SSRIs for 
treating PAs, including fluoxetine, paroxetine, and 
sertraline, and NRIs such as venlaflaxine. In regards to 
efficacy, TCAs are arguably as effective as SSRIs and NRIs, 
but they are considered a second-line approach for 
treating PAs and PD due to side effects and tolerability 
(Johnson, Federici, and Shekhar 2014).  
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CHAPTER II: Panic Disorder Theories: clinical 
research 
 
1) PD Theory based on Anxiety Sensitivity 
The concept of “anxiety sensitivity (AS)” refers to the fear 
of anxiety-related sensations, which arises from beliefs 
that these sensations have harmful somatic, 
psychological or social consequences, which can last over 
the anxiety episode (Reiss 1986). To measure this anxiety 
sensitivity, Reiss and colleagues (1986), have developed 
an “anxiety sensitivity index (ASI)” based on a 16 items 
questionnaire. It has been observed that ASI has a 
normal distribution in the population and can be 
considered a vulnerability factor which enhances the 
probability to develop an anxiety disorder.   
          AS has been associated with PD (Foot and Koszycki 
2004; White et al. 2006; Naragon-Gainey 2010), and the 
level of AS is greater among individuals with anxiety 
disorders in general (i.e., PD, social phobia, specific 
phobia, generalized anxiety disorder, obsessive-
compulsive disorder, post-traumatic stress disorder, and 
agoraphobia without panic) as compared with nonclinical 
controls (Olatunji and Wolitzky-Taylor 2009). However, 
prospective studies have shown that AS specifically 
predicts the onset of panic (Benítez et al. 2009) and that 
PD significantly differ from other anxiety disorders 
patients in AS levels, suggesting unique features of AS in 
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PD (Olatunji and Wolitzky-Taylor 2009). Further evidence 
of the correlation between anxiety sensitivity and panic 
disorder come from one study on neural activity in 
response to emotional stimuli in the corticolimbic 
network in a sample of patients affected by PD (Poletti et 
al. 2015). The main result of this study is a correlation 
between AS and brain activity in core structures involved 
in emotion processing in panic disorder [such as the 
amygdala, insula, cingulate and prefrontal cortex, which 
interact to identify the emotional significance of the 
stimuli and to generate and regulate affective states 
(Phillips et al. 2003b; Phillips et al. 2003a)]. Functional 
magnetic resonance demonstrated that higher levels of 
AS in PD patients, are associated to greater activations in 
anterior cingulate cortex (ACC) and insula in response to 
emotional faces (Poletti et al. 2015). This finding is 
consistent with the literature emphasizing the role of the 
insula and ACC in the processing of threat-related stimuli 
other than in the regulation of affective states and in the 
definition of the emotional significance of the stimuli 
(Phillips et al. 2003b; Phillips et al. 2003a). In addition, 
the insula and the ACC, together with midbrain 
periaqueductal gray matter, have been suggested to be 
involved in the pathophysiology of panic disorder (Graeff 
and Del-Ben 2008).  
          However these studies show some limitations. 
Indeed they do not clarify the cause of anxiety sensitivity 
and its role in the etiology of panic attacks and all studies 
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refer to single panic attack and no to the panic disorder 
at all. 
 
2) PD Theory of Catastrophic Misinterpretation 
One of the most important cognitive theories of panic 
disorder has been proposed by Clarks in 1986. Within this 
model, panic attacks are said to result from the 
catastrophic misinterpretation of certain bodily 
sensations. The sensations which are misinterpreted are 
mainly those involved in normal anxiety responses (e.g. 
palpitations, breathlessness, dizziness etc.) but also 
include some other sensations. The catastrophic 
misinterpretation involves perceiving these sensations as 
much more dangerous as they really are (e.g. perceiving 
palpitations as evidence of an impending heart attack or 
losing control or an imminent faint). These catastrophic 
thoughts produce anxiety and consequently increase the 
intensity of bodily sensations leading to a vicious circle 
that falls in a panic attack. The constant attention to the 
somatic sensations leads to a chronic vigilance and 
increased sensitivity to the normal physical sensations 
(Clark 1986).  
          Often this theory and the theory of anxiety 
sensitivity are considered together but actually there are 
some differences between them. The most peculiar is 
that in the theory of AS individuals who suffer of panic 
disorder are completely conscious of the causes of their 
sensations (do not misinterpreted them as in Clark’s 
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theory) but nevertheless they are frightened because 
they believe that these sensations can be physically or 
mentally harmful.  
          Many studies have been conducted to verify Clark’s 
theory (Khawaja and Oei 1998; Austin and Richards 
2001). First set of studies have demonstrated that 
inducing subjects to interpret bodily symptoms in 
catastrophic manner, it is possible to raise the level of 
vigilance and , in susceptible individuals , trigger panic 
attacks (Ehlers et al. 1988; Margraf et al. 1987) 
          Another set of research evaluated whether PD 
individuals had a higher attention towards neuro-
vegetative bodily sensations in comparison with healthy 
people. For example PD patients interpreted 
catastrophically ambiguous information related to 
internal sensations (McNally, Riemann, and Kim 1990) 
and they overestimated their heartbeats  (Ehlers et al. 
1995). 
          Other studies demonstrated that cognitive factors 
can influence the way in which PD patients interpret 
physiological reactions experienced after CO2 or sodium 
lactate administration, which are able to induce panic 
attacks. Indeed in several studies the possibility to 
interrupt the agents’ administration or the presence of a 
trusted person during these tests is able to inhibit the 
surge of panic attacks (Abelson et al. 2001; Salkovskis, 
Clark, and Hackmann 1991; Rachman, Levitt, and Lopatka 
1987). 
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Casey integrated the Clarks’ cognitive model with the 
theory of self-efficacy (figure 2) to explain the evidence 
that cognitive factors can decrease the likelihood of 
experiencing a panic attack as described in previous 
studies (Casey, Oei, and Newcombe 2004; Bandura et al. 
1987). 
According to supporters of cognitive models an increase 
of self-efficacy would be one of the mechanisms 
underlying the success of cognitive behavioral therapies. 
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Figure 2. Representation of Clark’s and Casey’s models of PD 
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Clark's theory has stimulated much research behind the 
new psychological therapy (cognitive behavioral therapy) 
effective in the treatment of PD but raised much criticism 
(Roth, Wilhelm, and Pettit 2005). Indeed the circularity of 
this model makes difficult to distinguish in time the 
causes and the consequences of panic attack and doesn’t 
explain the reason why PD patients associate unpleasant 
cognitive symptoms with potential threats (Windmann; 
Roth, Wilhelm, and Pettit 2005). 
 
3) PD Theories of Conditioning 
Conditioning theory has a long and distinguished 
tradition in helping to understand the etiology of anxiety 
disorders and it was one of the first types of theory 
applied to the cause of PD (Bouton, Mineka, and Barlow 
2001). Generally, conditioning theories suggest that 
when stimuli, events, or situations (conditioned stimuli 
[CSs]) are paired with a panic attack (and all of its 
associated physiological sensations), the learning that 
may occur can allow the CSs to trigger panic and anxiety 
when they are encountered again. This sort of theory has 
taken a number of different forms when applied to PD. 
Early conditioning theories focused on the role of 
conditioning in the onset of agoraphobia or situational 
panic attacks (i.e., conditioning to external or 
exteroceptive cues). However, perhaps the best known 
version of conditioning theory applied to PD originated in 
an important article by Goldstein and Chambless (1978) 
27 
 
that described a process they termed "fear of fear." In 
their work Goldstein and Chambless reintroduced the 
notion of interoceptive conditioning, in which low-level 
somatic sensations of anxiety or arousal effectively 
became CSs associated with higher levels of anxiety or 
arousal. Thus, they posited that early somatic 
components of the anxiety response can come to elicit 
significant bursts of anxiety or panic. These were also 
expected to generalize to other stimuli (Goldstein, A. J., 
& Chambless 1978). Thus, the focus of conditioning 
theory changed from exteroceptive conditioning in 
explaining agoraphobia and situational panics to 
interoceptive conditioning in explaining the cause of 
more "spontaneous" or apparently uncued panic attacks. 
Thus, interoceptive cues linked with the onset of an 
event can be associated with later aspects of the event. 
Collectively, this work is important in showing that an 
intero-interoceptive relation (RAZRAN 1961) forms with 
each drug administration such that animals learn to 
respond to an early event in anticipation of a later event. 
In an analogous fashion, early physiological changes 
during a panic attack may become signals for more 
intense and aversive physiological arousal (e.g., a panic 
attack, or intense fear) and thus elicit a panic attack (CR) 
on their own (Barlow 2002).  
For example, a slight rise in heart rate accompanying the 
beginning stages of a panic attack may become a 
conditioned stimulus (CS) signaling a larger rise in heart 
rate characteristic of the later stages of a panicogenic 
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response including other associated sensations (e.g., 
tachycardia, heart pounding, chest tightness, 
breathlessness). Such learned relations then alter the 
function of formerly benign bodily events such that they 
become significant fear-evoking events in their own right. 
Under the right conditions and in the context of relevant 
vulnerabilities (S Mineka and Zinbarg 1996) such learning 
may contribute to the development of hypervigilance, 
anxious apprehension, avoidance, and even panic 
disorder (Bouton, Mineka, and Barlow 2001; Barlow 
2002; Finlay and Forsyth 2009). 
       Recently Grillon and colleagues developed another 
theory based on conditioning (Grillon et al. 2007; Grillon 
2002). This theory starts from the evidence that 
individuals with panic disorder perceive panic attacks as 
unpredictable and because predictability is fundamental 
to Pavlovian conditioning, failure to predict panic attacks 
could be due to a basic deficit in conditioning. Results of 
their studies suggest that individuals with panic disorder 
suffer from a deficit in declarative associative learning. 
Such a deficit points to impaired hippocampal function 
that may disrupt cognitive processing of internal and 
external cues predictive of a panic attack (Grillon et al. 
2007; Grillon 2002). Further researches are necessary to 
define whether this deficit has a causal role in 
etiopathogenesis of panic disorder or is only a trait-
marker.  
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4) PD Theories basing on Separation Anxiety 
Donald Klein was the first to suggest that the separation 
anxiety disorder (SAD) during childhood could be a 
precursor of panic disorder in the adulthood (Gittelman R 
and Klein 1984; Klein 1964). Mattis and Ollendick have 
proposed a theory in which the separation anxiety or an 
intense discomfort, during a separation from attachment 
figures, could be an important way of PD development in 
children and adolescents (Mattis and Ollendick 1997). 
They speculated that repeated experiences of separation 
can scare children and grow in intensity until became 
panic attacks. Thus children with SAD, who live with 
great suffering the separation from caregivers, have a 
high risk to develop PD when experience numerous or 
prolonged events of separation. This last affirmation has 
been contested by Doerfler who find no correlations 
between the number or duration of separation 
experience and the risk to the develop PD (Doerfler, 
Toscano, and Connor 2008). 
           Most researches confirmed the strictly correlation 
between SAD and PD leading to suppose common 
mechanisms of development ( Battaglia et al. 1995;  
Bandelow et al. 2001; Aschenbrand et al. 2003; Doerfler, 
Toscano, and Connor 2008; Roberson-Nay et al. 2012). In 
this purpose a twin study conducted by Battaglia and 
colleagues (2009) demonstrated that shared genetic 
determinants appear to be the major underlying cause of 
the developmental continuity of childhood separation 
anxiety disorder into adult panic disorder and the 
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association of both disorders with heightened sensitivity 
to CO2. Inasmuch as childhood parental loss is a truly 
environmental risk factor, it can account for a significant 
additional proportion of the covariation of these 3 
developmentally related phenotypes ( Battaglia et al. 
2009). 
 
5) PD Theory of Hyperventilation 
Ley's (1982) hyperventilation theory of panic fear is the 
first respiratory theory about the etiology of panic 
disorder. This theory supposes that the panic attack 
consists of a synergistic interaction between 
hyperventilation and fear, the nature of which is a 
positively accelerating loop: with excessive expiration of 
CO2, moderate over-breathing produces relatively mild 
symptoms (e.g. slight dizziness) which can be tolerated 
for prolonged periods. If, however, respiration rate 
increases somewhat, the symptoms of hyperventilatory 
hypocapnea increase in both number and intensity very 
rapidly to the point where tolerance gives way to alarm 
and fear. Details of the reports of agoraphobics who 
suffered panic attacks indicate clearly that the symptoms 
of hyperventilatory hypocapnea preceded the experience 
of fear (Ley 1988; Ley 1985).  
          This theory is much debated, indeed, while some 
clinical evidence seems to support it, many studies seem 
to refute it entirely. In first case the symptomatology of 
hyperventilation syndrome show many common features 
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with PD, such as dyspnea, sense of suffocation, dizziness 
and anxiety (Gardner 1996). On the other hand several 
studies in which individuals were been instructed to 
hyperventilate obtained controversial results. Indeed 
these studies did not demonstrate that the 
hyperventilation lead to trigger panic attacks in PD 
patients (Garssen, Buikhuisen, and van Dyck 1996; 
Wilhelm, Gerlach, and Roth; Gorman et al. 1988; Nardi et 
al. 2004). 
These results demonstrated that, although low level of 
pCO2 is common in some panic attacks and maybe in 
basal conditions in PD patients, much panic attacks are 
triggered by mechanisms different from hyperventilation.  
          Thus these findings have led some researchers to 
consider falsified the theory of Lay (Roth, Wilhelm, and 
Pettit 2005). 
 
6) PD Theory of false alarm suffocation 
A few years later the Ley’s theory, Klein proposed the 
theory of “false alarm suffocation” for the etiology of PD 
(Klein 1993). This theory suggests a physiological 
misinterpretation by the control center of an advanced 
and sophisticated suffocation alarm system. This 
produces sudden respiratory distress followed swiftly by 
a brief hyperventilation, panic, and the urge to flee. 
Carbon dioxide hypersensitivity is seen as due to the 
deranged suffocation alarm monitor.  
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          Between Ley’s and Klein’s theories there is a 
significant difference concerning the role of the 
hyperventilation: in Ley’s theory the hyperventilation is 
the cause of panic attacks whereas in the Klein’s theory is 
a compensatory response to a false alarm of suffocation 
(Roth, Wilhelm, and Pettit 2005). 
          
Klein’s theory is the result of an intense clinical research 
on CO2 inhalation in PD patients. Although already in 
1951 Cohen and colleagues (COHEN et al. 1951) 
described the panicogenic properties of CO2, only in the 
80's some researchers developed experimental protocols 
that involved the CO2 inhalation. For example in a study 
of Van den Hout the inhalation of air mixture compose by 
35% CO2 and 65% O2 was able to trigger in healthy 
subjects a short but intense respiratory response 
accompanied by neurovegetative symptoms similar to 
those reported during a panic attack (Van den Hout and 
Griez 1984). However in PD subjects the similar 
procedure was able to induce a transient increment of 
anxiety similar to that experienced during a panic attack 
(M. R. Fyer et al. 1987; Griez et al. 1987; G Perna et al. 
1994; Nardi et al. 2000). The CO2-hypersensitivity 
observed in PD patients is not present in subjects 
suffering of generalized-anxiety disorder, phobia, 
obsessive compulsive disorder or mood disorder (G 
Perna et al. 1999; Verburg, Griez, and Meijer 1994; G 
Perna et al. 1995).  
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Gorman and colleagues developed a different protocol 
during which twenty minutes inhalation of 5% CO2 
enriched air mixture provoked an intense panic attack 
and demonstrated that this procedure was more 
panicogenic than the voluntary hyperventilation (Gorman 
et al. 1984). 
Over the years many variation of these protocols have 
been developed, with different concentrations or time of 
administration but independently from the protocol the 
CO2 inhalation is able to trigger panic attacks more in PD 
patients than in healthy subjects [for a review including 
the different protocols see (Rassovsky and Kushner 
2003)].  
          Several studies demonstrated also an abnormal 
respiratory response to CO2 in PD patients including a 
higher increment of breathing frequency, of tidal volume 
and minute ventilation after CO2 inhalation (Sardinha et 
al. 2009; Maddock & Carter 1991; Wilhelm et al.2001).  
Overall clinical studies demonstrated that PD patients 
also show high variability in several respiratory 
parameters, also in basal conditions, suggesting a 
possible malfunctioning in breathing control system 
supporting Klein’s theory (Abelson et al. 2001; Schwartz 
et al. 1996). In particular, according to this theory 
substances that stimulate the breathing highlight 
alterations already present in the basic condition in PD 
subjects. 
        In addition the chronic administration of antipanic 
drugs (such as SSRI or TCA) in PD patients was able to 
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decrease CO2 reactivity (Bertani et al. 1997; Pols et al. 
1996; Giampaolo Perna et al. 2002). These findings 
suggested that the CO2 hyper-reactivity can be a central 
trait for PD and a useful model to study this disorder. 
          The theory of false alarm suffocation stimulated 
scientific activity and studies highlighting the relationship 
between CO2 hypersensitivity, respiratory disorders in PD 
patients and SAD (as above mentioned in paragraph 4.4). 
Additional evidence in support of Klein’s theory is the 
alteration in neurotransmission systems involved in 
breathing, in PD subjects, that will be describe in next 
section. 
6.1) Neurobiological basis and substrates of Panic 
disorder 
The first neurobiological theory of panic disorder has 
been proposed by Gorman and colleagues in 1989 and 
then revised in 2000 (Gorman et al. 1989; Gorman et al. 
2000). These authors suggested that PD comes from an 
abnormal sensitivity of fear conditioning networks. These 
complexes have been extensively studied by LeDoux and 
Davis, and involved prefrontal cortex, insula, thalamus, 
amygdala and its projection toward the brainstem. 
          Clinical and preclinical studies demonstrated the 
importance of amygdala in fear perception and panic 
response as well. In humans amygdala stimulation elicits 
responses similar to anxious responses whereas bilateral 
lesions of this structure decrease anxiety and fear 
(Adolphs et al. 1994; Adolphs et al. 1995). Neuroimaging 
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studies demonstrated that the amygdala is active during 
observation of scared but no happy faces (Morris et al. 
1996). According to Gorman’s model the sensory input of 
the conditioned stimulus crosses the anterior thalamus, 
reaches the lateral nucleus of amygdala until arrives in 
the central nucleus of amygdala. This latter nucleus 
represents the control center of information that 
coordinates autonomic and behavioral responses 
(figure3).  
 
 
Figure 3. Neuroanatomical pathways of viscero-sensory 
information in the brain (Gorman et al 2000) 
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Projections from the central nucleus of amygdala reach 
several areas: the parabrachial nucleus that produces an 
increment in breathing; the lateral nucleus of 
hypothalamus that activates sympathetic nervous system 
causing autonomic arousal; the locus coeruleus that 
contributes to the heartbeat increment and to the fear 
response; the periaqueductal gray substance responsible 
of defensive behaviors. In addition the hippocampus 
maintains contextual information. Moreover the 
amygdala receives information also from cortical regions 
involved in processing and evaluation of sensory 
information. According to the Gorman’s theory, panic 
disorder depends on deficits in some of these structures 
(figure 4) (Gorman et al. 2000; Ohta et al. 2008; Tanii et 
al. 2009; Eduard Maron et al. 2004).  
          Further evidence support the role of amygdala and 
brainstem structures in panic disorder demonstrating a 
linkage between the CO2 hypersensitivity and acid 
sensing ion channels (ASIC) which are activated by 
acidosis (following CO2 inhalation) and are localized in 
several structures including amygdala and brainstem. 
ASICs are also linked to PD (Smoller et al. 2014; Ziemann 
et al. 2009; Maren 2009).  
37 
 
 
 Figure 4. Panic attack mechanism (Sardinha et al. 2009)          
 
Gorman and colleagues proposed a putative circuit that 
might be involved in PD and a theory for the etiology of 
this disorder (figure 5). According to this model, PD 
subjects have genetic vulnerability to the disorder. Early 
adverse events and attachment binding alterations can 
produce hypersensitivity in the network which mediates 
fear conditioning response, through a gene environment 
interaction. 
These conditioning mechanisms could be also involved in 
avoidance behaviors typical in panic disorder. 
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Figure 5. Causal modeling of panic disorder theory (L. Fava and 
Morton 2009).  
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CHAPTER III. Panic Disorder (PD): pre-clinical 
research 
 
Due to the impossibility to interview animals and ask 
them about feelings and sensations, animal models of 
panic are usually based on exposure to dangerous 
context, trying to discriminate between animal responses 
to real or potential threat, between fear and anxiety, 
between panic and generalized anxiety disorder.  The 
reaction to diverse drugs, whose differential 
effectiveness has already been measured in human 
patients, is needed to validate the animal model.  
The etho-experimental approach has laid the foundation 
for the preclinical study of emotions and emotional 
disorders, even if this reasoning does not allow exploring 
the molecular mechanisms underlying anxiety disorders, 
and new therapeutic strategies. This approach is based 
on the empiric observation of defensive behaviors 
showed by animals and according to this examination in 
1988 Blanchard and Blanchard have provided a 
behavioral, functional and pharmacological distinction 
between anxiety and fear (D. C. Blanchard and Blanchard 
1988).  The discrimination between these behaviors has a 
strong relevance for the pre-clinical approach in the 
study of emotional disorders such as panic disorder or 
generalized anxiety disorder (GAD).  
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          The function of fear is to prompt the animal to 
move away from a real and imminent danger, such as  
when a rat is in proximity to a cat. Behaviors showed by 
the animal differ depending on the presence or not of an 
escape way. In the presence of a way out the animal will 
move away, whereas other defensive strategies such as 
immobility and attack will be shown by the subject 
whether there is no possibility to elude such situation (D. 
C. Blanchard and Blanchard 1988). Both these defensive 
strategies are decreased by antipanic drugs such as SSRI 
and TCA but not by drugs used in anxiety disorder (GAD) 
(D. C. Blanchard, Griebel, and Blanchard 2001; 
Poltronieri, Zangrossi, and de Barros Viana 2003). 
          The function of anxiety responses is to prepare the 
individual to detect and deal with threats. Anxiety 
facilitates reaching the individual’s goals, by adopting a 
more careful approach when potential dangers are 
detected, such as for example the presence of predator. 
In this case anxiety induces behaviors of risk assessment 
and defensive quiescence (D. C. Blanchard and Blanchard 
1988; McNaughton and Corr 2004). These behavioral 
strategies are instead decreased by treatments for GAD 
but not by them used in PD (D. C. Blanchard, Griebel, and 
Blanchard 2001). 
          The etho-pharmacological approach has laid the 
basis for studying emotions such as fear and anxiety in 
animals. In addition pharmacological studies support the 
theory which sustain that PD is due to alteration in fear 
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circuits and not in anxiety ones (McNaughton and Corr 
2004). 
          Animal models of PD are based on the analysis of 
defensive behavior in response to different kind of 
stimulus. According to the stimulus used to elicit 
defensive behavior tests are classified in: 1) tests based 
on predator exposure; 2) tests based on conditioning 3) 
tests based on structures’ stimulation and on 
administration of substances (such as sodium lactate and 
CO2). These tests will be described in the following 
paragraphs. 
 
1) Animal Test for studying PD  
 1.1) Test based on predator exposure 
Rodent models of PD are based on the analysis of 
defensive behaviors. Cognitive symptoms during a panic 
attack, for example fear of dying, are suggested to be 
considered homologous to those attributable to rat when 
exposed to a cat (McNaughton and Corr 2004). 
          Blanchard and colleagues developed a paradigm in 
which rats are exposed to predator (cat) and this 
paradigm permits to study behaviors related to fear. If 
there is no escape way, the rat shows freezing behavior 
(immobility) for the majority of time of predator 
exposure. This paradigm has also good pharmacological 
validity indeed antipanic drugs, such as imipramine, 
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decrease the avoidance behavior during threatening 
stimulus exposure (R. J. Blanchard et al. 1997). 
          A similar test, namely “rat exposure test (RAT)”, has 
been developed for the mouse. In this case a mouse is 
exposed to the presence of a predator (an awake rat) 
separated by a wire grid (figure 6) (Yang et al. 2004). 
During this test several behavioral parameters are 
measured: time spent by the mouse in each section of 
the apparatus, time in contact with the grid and 
defensive behaviors such as stretch attend posture or 
freezing or burying (tunnel closing with the bedding). 
Some of these behaviors, such as latency to flight, have 
been associated with fear response.   
 
 
  Figure 6. Schematic side view of rat exposure test (RAT) 
(Campos et al. 2013) 
This test has been pharmacologically validated for the 
study of anxiety disorders: administration of anxiety-
inducing drugs induced an enhancement in avoiding 
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behaviors, whereas the administration of anxiolytics, 
such as benzodiazepine, leads to reduction of these 
behaviors (Carvalho-Netto et al. 2007; Litvin et al. 2007). 
In addition, it has been recently demonstrated that the 
defensive response in this test is also sensitive to drugs 
known either to attenuate (alprazolam and chronic 
fluoxetine) or induce (caffeine) panic attack in humans, 
suggesting the RET as a useful test to assess the effects of 
panicolytic and panicogenic drugs, as well (Campos et al. 
2013). 
          A similar, more complex behavioral test eliciting 
defensive behaviors in rodents is the “mouse defense 
test battery (MDTB)”. 
The MDTB consists of five tests associated either with 
potential threat (contextual defense) or with the actual 
presence of an approaching threat (i.e. a rat). After a 
period of habituation in the apparatus, a rat is 
approached to the subject at various speeds. Defensive 
behaviors showed by the mouse, in the presence of the 
approaching rat, as flight, avoidance, freezing and attack 
are considered fear indices. Once the rat is removed, risk 
assessment behaviors are shown by the mouse and these 
behaviors have been considered anxiety indices (Griebel, 
Blanchard, and Blanchard 1996). 
This test has been pharmacologically validated both with 
anti-panic and anti-anxiety drugs. Anti-panic drugs 
(fluoxetine, SSRI, imipramine) potentiated in acute the 
flight response, with chronic treatment decreasing the 
intensity of these reactions, as in clinical observations. In 
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addition panicogenic substances (e.g. yombina) 
potentiated the flight response (Griebel et al. 1995; 
Griebel, Perrault, and Sanger 1997; Blier and Ward 2003; 
Eduard Maron and Shlik 2006; R. J. Blanchard et al. 
1997). 
          Overall, the paradigms described are based on the 
exposure of the animal to a predatory threat. The 
quantitative and qualitative analysis of avoidance 
behaviors provides a measure of fear. Pharmacological 
studies have shown good validity of these models for the 
study of panic disorder, using drugs already known for 
their effects in the clinical practice. 
1.2) Test based conditioning 
Models based on conditioning are among the first 
developed for the study of panic (Bouton, Mineka, and 
Barlow 2001). Fear conditioning paradigms have been 
widely used in preclinical research for the study of 
networks involved in fear response. Panic disorder is 
considered a disease related to fear as described in the 
first chapter (D. C. Blanchard, Griebel, and Blanchard 
2001; McNaughton and Corr 2004). For this reason 
experimental research in preclinical field can suggest 
possible networks altered in PD patients. 
          In fear conditioning experiments a neutral stimulus 
(CS) or context is associated with an aversive 
unconditioned stimulus (US), for example a foot-shock. 
The behavior showed by the animal, for example 
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freezing, is used as conditioning index (Fanselow and 
Bolles 1979; Young and Fanselow 1992). 
          A fear-potentiated startle response (FPS) is also 
used as fear conditioning test and this response depends 
on classical pavlovian learning. The amplitude of the 
startle response elicited by a stimulus (for example a 
loud noise) is measured concurrently or less than a CS 
previously coupled to an aversive stimulus (e.g. foot-
shock). A measure of fear is obtained subtracting the 
amplitude of the two startle responses (Grillon 2002). 
The advantage of this test is the possibility to measure 
fear levels at a specific time point. 
          Although pre-clinical studies demonstrated the 
existence of conditioning mechanisms involved in anxiety 
disorder including panic disorder (as described in first 
chapter) there are not yet enough clinical research that 
confirm their importance in the etiology of panic disorder 
so it is necessary more research in this field. 
 
1.3) Test based on administration of human 
panicogenic substances  
There are some substances which have panicogenic 
properties such as sodium lactate, CO2 and doxapram 
hydrochloride and clinical and pre-clinical research have 
widely used them for studying PD. 
          Doxapram hydrochloride is a respiratory stimulant 
with panicogenic effects (Abelson et al.; Abelson et al. 
1996). Preclinical evidence demonstrated that the 
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doxapram mechanism of action depends on the direct 
stimulation of chemoreceptors localized on carotid 
bodies and brainstem. Doxapram is able to induce 
panicogenic effects as high levels of anxiety, panic 
attacks, increment of respiratory frequency (Abelson et 
al. 1996; Y. J. Lee et al. 1993).  
Sullivan and colleagues demonstrated that the 
administration of doxapram is able to induce both 
anxiety and panic measurable in different animal tests: 
contextual, cue fear conditioning, open field and social 
interaction tests. They also demonstrated that its effect 
depends on the activation of central nucleus of 
amygdala. Clinical evidence suggested an higher 
reactivity to this substance in PD patients in comparison 
with healthy subjects suggesting the use of doxapram to 
validate animal models of panic disorder (Sullivan et al. 
2003). 
          A different substance used in preclinical PD 
research is the sodium lactate. Clinical research 
demonstrated that sodium lactate infusion induces 
hyperventilation, enhancement of heartbeat rate and 
blood pressure and cognitive symptoms similar those of 
panic attack. In addition PD patients are more 
susceptible to the substance in comparison with healthy 
subjects or individual who suffer of different psychiatric 
disorders (Gorman et al. 1986; Liebowitz et al. 1985). In 
2000 Sajdyk and colleagues developed a paradigm using 
sodium lactate. Physiological response to the substance 
was detected through a catheter in freely moving rats 
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while an arousal behavioral index was detected during 
the analysis of social interaction test. Authors observed 
that rats responded to a lactate infusion with significant 
increases in heart rate, blood pressure and experimental 
anxiety. They also demonstrated the role of basolateral 
nucleus of amygdala in this phenomenon; indeed rats 
which were primed with chronic subthreshold GABA 
receptor blockade in the basolateral nucleus developed a 
sensitivity to sodium lactate, similar to human panic 
disorder patients (T. J. Sajdyk and Shekhar 2000; T. 
Sajdyk et al. 2008). These results are in agreement with 
the evidence which suggests a role of basolateral 
amygdala and fear networks in panic disorder. However 
the Sajdyk’s paradigm needs of pharmacological 
validation. 
          As extensively described in 4.6 section, CO2 is able 
to induce panic attack in PD patients. Inhalation of CO2 
demonstrates several interesting characteristics as a 
model to induce panic in the laboratory. Not only is the 
inhalation of CO2 an efficient means of provoking panic 
and anxiety in PD and healthy individuals but it is also a 
relatively easy and non-invasive procedure (Rassovsky 
and Kushner 2003). In addition CO2 sensitivity is a 
common trait in all animals and can represent an useful 
endophenotype to measure and investigate panic 
disorder molecular mechanism, using a real translational 
approach (as described above in this work) (Marco 
Battaglia and Ogliari 2005; T. J. Sajdyk and Shekhar 2000). 
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There is few preclinical research in this field (D’Amato et 
al. 2011) and further  investigation on the potentiality of 
this endophenotype to measure panic in animals, as well 
as in humans is presented in here. 
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EXPERIMENTAL SECTION 
 
AIMS 
In this section I will describe the aims of the different 
experiments performed during my PhD. 
EXPERIMENT 1 
The first aim was to validate the Repeated cross fostering 
(RCF) protocol in mice as a useful manipulation 
procedure affecting individual emotionality. This method 
differs significantly from the classical maternal 
separation (Handling) usually applied in rodents in order 
to evaluate the effects of an early adverse environment. I 
assesed the short and long-term effects of these early 
manipulations, comparing the Handling and the RCF 
protocols in outbred mice. Several behavioral, molecular 
and physiological parameters (mother-pups interaction; 
stress response; emotionality; CO2 panic-related 
response; gluco- and mineral-corticoid receptors mRNA 
expression; etc.) have been considered. 
EXPERIMENT 2 
The aim of the second experiment was to analyze 
possible molecular mechanisms underlying the panic-
related CO2 hypersensitivity showed by RCF animals 
(Experiment 2a). Moreover, on the basis of the molecular 
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suggestions founded in this first part, I evaluated 
different pharmacological treatments (chloridiazepoxide, 
chlorogenic acid and amiloride) able to recover the 
normal respiratory response to hypercapnia (Experiment 
2b). 
EXPERIMENT 3 
The aim of the third experiment was to verify the 
cognitive capability of RCF animals trough learning tests 
(such as active avoidance test and novel recognition test) 
and investigate the capability of 6% CO2 exposure to 
condition animals’ behaviors, in RCF and Control 
subjects. Indeed, humans with PD show behavioral 
conditioning to panic attacks and develop PA also in 
absence of unconditioned stimulus.  
EXPERIMENT 4 
The aim of the fourth experiment was to investigate 
whether the CO2 hypersensitivity showed by RCF animals 
was a transgenerational transmissible trait.
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Experiment 1. Short- and long-term 
behavioral effects of two different 
manipulations of the early environment: 
comparison between Handling and 
Repeated Cross Fostering 
 
INTRODUCTION 
The developmental programming hypothesis suggests 
that the early environment, whether by nutritional, 
hormonal or behavioral processes, can give rise to 
persistent modifications of the adult phenotype. In 
particular, when facing a challenging environment, 
epigenetic modifications may occur that modify the 
behavioral, physiological, hormonal and neurobiological 
profile of the developing individual, to optimize its future 
coping strategies (Bock et al. 2014). Several studies in 
rodents have investigated the effects of a challenging 
environment, experimentally altering the external or 
internal pup’s milieu, and various postnatal 
manipulations, differing for severity, time and duration 
schedules have been applied to developing animals. In 
the majority of studies ( see also Moles et al. 2004; Moles 
et al. 2008) pups were directly stressed exposing them to 
low temperature, poor mothering, saline injection, 
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unfamiliar odors and others (Oddi, Luchetti, and D’Amato 
2015). The most common manipulation applied to 
developing rodents consisted in exposing young animals 
to daily sessions of separation from the mother during 
the first 1–2 weeks of life (Pryce & Feldon, 2003). 
Maternal separation is adversative and pups search for 
the mother by emitting calls and by seeking olfactory and 
thermal cues of her presence. This indicates the 
establishment of an attachment bond between the infant 
and the mother in the first 2 weeks of life, with signs of 
distress (e.g., ultrasonic vocalizations (USVs)) following 
maternal separation that are already detectable in the 
first few postnatal days (PNDs). Rather than repeated 
separations, unpredictability of the early environment 
may represent a stressful condition for pups. Repeated 
cross-fostering (RCF) has been used in mice as a 
postnatal manipulation to model human early 
environmental instability, a risk factor for internalizing 
disorders (including separation anxiety disorder-SAD-, 
panic disorder-PD-and CO2 hypersensitivity, (K S Kendler 
et al. 1992; Forman and Davies 2003; Marco Battaglia et 
al. 2009)). Even though animal models are not expected 
to reproduce clinical disorders exactly, a translational 
model of PD should allow to differentiate panic attack 
(PA) from fear, on the basis of respiratory symptoms 
(over-reaction to hypercapnia) and lack of increments in 
stress hormones (Schenberg et al. 2014). Cross-fostering 
is a routine procedure used in many laboratories that 
consists in giving pups to a lactating female different 
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from the biological mother, usually within 24–48 h from 
birth (Oddi, Luchetti, and D’Amato 2015). RCF consists in 
repeating the same procedure every day for the first 4 
days of life. Changes in maternal (olfactory, gustatory, 
tactile, thermal, etc.) cues connected with the RCF 
procedure may disrupt the associative learning process 
that is necessary for establishment of the attachment 
bond in the developing infant (Landers and Sullivan 
2012). 
The temporary separation from the mother, or the 
absence/malfunctioning of the attachment bond (RCF 
protocol) may act on different molecular system and 
differently affect the development of emotionality and 
vulnerability to specific psychopathologies. In this 
experiment, we evaluated the short- and long-term 
behavioral effects of two different manipulations of the 
early environment. In one case pups experienced short 
separations (Handling) from the mother, which interferes 
with continuity of the bond; in the other case, pups 
experienced the Repeated Cross-Fostering procedure, 
which is aimed at interfering with bond formation. The 
effects of maternal separation in rodents, mice 
especially, yield little agreement among laboratories and 
strains (see for example Millstein and Holmes, 2007). 
To help resolving these issues, I analyzed the specificities 
of the RCF vs. Handling protocols effects on behavioral 
readouts and on the panic-related respiratory responses 
to carbon dioxide (CO2) among outbred strains in the 
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same laboratory. Different response to these 
manipulations would support the relative selectivity of 
behavioral and molecular mechanisms involved in 
response to different types of adversities. 
 
MATERIALS AND METHODS 
 
Animals 
NMRI outbred mice (Harlan, Italy) were used in all 
experiments. Mice were mated when they were 12 
weeks old. Mating protocol consisted in housing 2 
females with 1 male in transparent high temperature 
polysufone cages (26.7 × 20.7 × 14.0 cm) with water and 
food available ad libitum. Room temperature (21 ± 1 ◦C) 
and a 12:12 h light dark cycle (lights on at 07.00 p.m.) 
were kept constant. After 15 days, males were removed 
and pregnant females were isolated, left in clean cages, 
and inspected twice a day for live pups. All animal used 
procedures were in strict accordance with standard 
ethical guidelines (European Community Guidelines on 
the Care and Use of Laboratory Animals 86/609/EEC) and 
the Italian legislation on animal experimentation 
(DecretoL.vo 116/92). 
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Experimental Manipulations 
On PND1 litters were culled to 8 pups (4 males and 4 
females) and assigned to handling (H) or repeated cross-
fostering (RCF) procedure  
 
Repeated cross-fostering 
On postnatal day 1 (PND1), after having spent the day of 
birth (PND0) with the biological mother, litters were 
culled to 8 pups (4 males and 4 females) and assigned to 
experimental Repeated Cross Fostering (RCF) or control 
(CT) treatment. Differently from the ‘‘classical’’ cross-
fostering procedures (Bartolomucci et al. 2004), RCF pups 
changed caregiver every 24 h: 4 times in the PND1-PND4 
time interval by following a rotation scheme, each dam 
shifted to 4 different litters and each litter was shifted to 
4 different dams (see also Figure 1). The daily procedure 
consisted of first removing the mother from the cage, 
then removing its entire litter, and immediately 
introducing this litter into the home cage of a different 
dam whose pups had just been removed. The RCF pups 
were then semi covered with the home cage bedding of 
the adoptive mother, which was then reintroduced in the 
cage and left with this litter for the next 24 h. The entire 
procedure lasted about 30 s and took place every day 
between 10.30 and 11.00 a.m. This was repeated daily, 
four times until reaching the fourth adoptive mother, 
with which pups were left until weaning (PND0: 
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biological mother, PND1-PND4: adoptive mother 1–4, 
PND4-PND28: fourth adoptive mother- Figure 1). 
Adoptive dams were lactating females with pups of the 
same age as fostered litters. Control litters (CT) were 
picked up daily and reintroduced in their home cage, 
covered with home cage bedding and had their biological 
mothers returned within 30 s; this procedure took place 
from PND1 to PND4 in order to control the possible 
effect of manipulation necessarily required by RCF 
procedure.  
 
 
 
 
Figure 1. Schematic representation of RCF procedure. Pups 
"a" born from mum "A" spend the first day (D0) with their 
mum. Then they change caregiver for four consecutive days 
spending D1 with mum "B", day 2 with dam "C", day D3 with 
mum "D" and finally from D4 to weaning with adoptive mum 
"E". Also pups “b, c, d, e” receive the same treatment. 
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A total of two experimental groups resulted from the 
early manipulation: RCF and their controls (RCF and CT). 
Animals were weaned when 28 days old, and then 
separated by sex and left in cage with littermates. A total 
number of 10 RCF and 10 CT litters were used for all 
experiments described in this thesis. 
 
Handling  
According to the well validated paradigm called 
‘‘handling’ ’(Pryce et al. 2005) pups were  briefly handled 
and separated from the dam for 15 min daily. This 
procedure took place from PND1 to PND14 between 9:30 
and 11:00 am. Controls litters (N-H), once completed the 
culling procedure, were left undisturbed for the first 2 
weeks of life. A total of two experimental groups resulted 
from the early manipulation: Handled (H) and their 
controls (N-H). Animals were weaned when 28 days old, 
and then separated by sex and left in cage with 
littermates. A total number of 10 H and 10 N-H litters 
were used for all experiments described in this thesis. 
 
Short and Long-Term Effects of Repeated cross-
fostering manipulation 
 
The effects of H and RCF on offspring were compared 
according to eight different physiological, molecular, and 
behavioral parameters collected during development and 
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adulthood. Body weight (1) was measured in infancy 
(PND8) and adulthood (PND90). Maternal behavior (2) 
was observed during the first week of life to exclude the 
action of poor nurturing on offspring’s responses. USVs 
(3) in response to isolation (PND8), and sociability and 
social preference (4) were measured before (PND28) and 
after weaning (PND35), respectively. Adult males 
(PND75–90) were also tested for behavioral emotionality 
(5), HPA axis functionality as indicated by corticosterone 
response to stress (6) and hippocampal mRNA levels of 
the glucocorticoid and mineralcorticoid receptors (7) 
were also measured. In addition, respiratory responses 
(8) to a 6% CO2-enriched air mixture were evaluated in 
young and adult animals. 
 
Maternal Behavior  
 
Maternal behavior was observed daily from PND2 to 
PND7 by an observer unaware of the litter’s 
manipulation (H, N-H, RCF and N-RCF) in two daily 
sessions (12.00–12.30 and 16.00–16.30) in the facility 
room. The first daily session took place at least 1 h after 
the cross-fostering/maternal separation procedures, in 
order to facilitate the dams’ acclimatization. Maternal 
behavior encompassing: (a) NURSING, including the 
arched-back and blanket postures; and (b) GP/L: 
grooming and licking pups was monitored with an 
instantaneous sampling method (1 sample every 2 min), 
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for a total of 16 sampling points/session (Shoji and Kato 
2006a). 
 
 
Ultrasonic Vocalizations (PND8) 
 
Pups’ behavior was evaluated at PND8, by measuring 
USVs emitted during 5 min of isolation (Moles et al. 
2004; Cryan & Holmes 2005). Experimental animals were 
transferred in their home cage to the experimental 
rooms for USVs assessment, 1 h prior to testing. After 
this period of acclimatization, the mother was removed 
and transferred into a clean cage, while pups were left in 
the home cage standing on a warm plate set at the 
temperature of 35 °C to prevent cooling. Each pup was 
individually placed for 5 minutes into a beaker containing 
clean bedding and the vocalizations were recorded. Four 
pups of each litter were tested. USVs were recorded 
using an UltraSoundGate Condenser Microphone (CM16, 
Avisoft Bioacoustics, Berlin, Germany) lowered 1 cm 
above the top of the isolation beaker containing the pup. 
The microphone was sensitive to frequencies of 15–180 
kHz with a flat frequency response (± 6 dB) between 25–
140 kHz. It was connected via UltraSoundGate USB Audio 
device to a personal computer, where acoustic data were 
recorded as wav files at 250,000 Hz in 16 bit format. 
Sound files were transferred to SasLab Pro (version 4.40; 
AvisoftBioacoutics) for sonographic analysis and a fast 
Fourier transformation was conducted (512 FFTlength, 
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100% frame, Hamming window and 75% time window 
overlap). Spectrograms were produced at 488 Hz of 
frequency resolution and 0.512 ms of time resolution. To 
detect ultrasonic vocalizations, an automatic threshold-
based algorithm and a hold time mechanism (hold time: 
20 ms) were used. Signals below 30 kHz were truncated 
to reduce background noise to 0 db. Inaccurate 
detections were adjusted manually by an experienced 
user before running the automatic parameter analysis. 
The total number of vocalizations emitted in 5 minutes 
was measured. 
 
Sociability and Social Preference 
 
Sociability and social preferences were evaluated in male 
mice at PND28 (before weaning), and at PND35 (1 week 
after weaning), respectively, in different animals (Cinque 
et al. 2012). Measures of interest in an unknown 
conspecific vs. an unknown object were employed as 
indicators of sociability. Indices of social preference were 
acquired to test whether H and RCF affected siblings’ 
recognition. The social preference test was performed 1 
week after weaning to reduce the impact of the mother 
on sibling’s olfactory cues. Both tests used a gray 
Plexiglas rectangular box (60X40X24 cm) consisting of 
three interconnected chambers. Each of the two lateral 
compartments contained a circular transparent Plexiglas 
cylinder (diameter: 8 cm, height: 15 cm) with multiple 
holes (diameter:1.2cm) yielding olfactory cues. Mouse 
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behavior was recorded by a video camera and analyzed 
with the SMART video tracking system. Each subject was 
placed inside the central compartment and explored the 
apparatus for a 10 minutes habituation period, with the 
doors on either side left open. During the 10 min social 
session of the test, the tested animal was exposed to an 
unfamiliar animal and a white object of similar size 
(Sociability test), or was simultaneously exposed to an 
unfamiliar (same strain, age and treatment) and a 
familiar male mouse (sibling) (Social preference test). 
Each partner and object was confined in one of the two 
Plexiglas cylinders located in the lateral compartments, 
for 10 min. The position of stimuli (partners and objects) 
in the apparatus was equally distributed between the left 
and the right compartment. Collected measures included 
time spent: (a) in each one of the three compartments; 
and (b) in the immediate proximity (2 cm: Time Close) of 
each cylinders.  
 
Emotionality 
 
Male mice were tested in the elevated plus maze at 
PND75–90 for emotionality. No more than 2 males X 
litter for group were sampled. The elevated plus maze 
consisted of 2 open (5 cm wide, 30 cm long) and 2 closed 
arms (5 cm wide, 30 cm long, enclosed by a wall of 14 cm 
in height) arranged in a plus configuration, joined by a 
central square of 5 cm X 5 cm. The apparatus was made 
of opaque Plexiglas and kept on a base 40 cm above the 
62 
 
floor. All animals were exposed to a test of 5 min 
duration. At the beginning of the test each mouse was 
placed individually in the center of the maze, with the 
head facing an open-arm (the same for all mice). All tests 
were conducted between 13:00 h and 15:00 h and 
recorded by a video camera. The animals were initially 
accustomed to the experimental room for at least 1 hour 
before the experiment.  
 
HPA Axis Functionality: Corticosterone response to 
novelty 
 
Corticosterone levels were measured in H, N-H, RCF and 
N-RCF male mice, at different time intervals from novelty 
exposure. Apart from the postnatal manipulation, these 
animals have never been exposed to other experimental 
procedures. Novelty consisted in exposing the animals to 
a novel environment: each mouse was removed from its 
home cage and placed in the center of an open circular 
arena (60 cm diameter) for 20 minutes. Trunk blood 
samples were collected at different time intervals after 
the novelty test. One group of animals for each 
treatment was not manipulated at all and blood collected 
represented the group baseline (Time 0'). Immediately at 
the end of the novelty exposure, 50% of mice were 
sacrificed to measure the stress response to the open 
arena (Time 20'), while the other 50% was reintroduced 
in their home cages and blood was collected after 40 min 
(Time 60'). After blood centrifugation (20min, 4 °C, 4000 
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rpm), serum samples were stored at -25 °C until assay 
were conducted. Corticosterone levels were measured 
using commercially available EIA kits (Enzo LifeScience, 
sensitivity 27.0 pg/mL). All corticosterone measures were 
carried out in duplicate. 
 
Hippocampal mRNA Analyses: GR and MR 
expression (Real-time PCR analysis) 
 
Brains of adult male mice of the Time 0 groups for 
corticosterone essays were rapidly removed and placed 
onto an ice-cooled metal plate. Hippocampi were 
dissected and samples were immediately frozen on dry 
ice and stored at -80 °C. RNA was extracted from 
homogenized hippocampi (N = 5/7 for each experimental 
group) using a Total RNA purification kit (Norgen Biotek, 
Thorold, ON, Canada) following the instructions of 
manufacturer. RNA quantity was determined by 
absorbance at 260 nm using a Nano Drop UV-VI 
Sspectrophotometer (Thermo Fisher Scientific, 
Wilmington, DE, USA). RNA was reverse transcribed with 
a High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystem, Paisley, UK) according to the manufacturer’s 
instructions. Equal amounts of cDNA were then 
subjected to real-time PCR analysis with an Applied 
Biosystems 7900 HT thermal cycler, using the SensiMix 
SYBR Kit (Bioline, London, UK) and specific primers, each 
at a final concentration of 200nM (Nr3c1: sense: 
CCTCCCAAACTCTGCCTGG , antisense AGCACAAA 
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GGTAATTGTGCTGT; Nr3c2: sense CGGCTTCAGCTGACC 
TTTGA, antisense TGGCTCTTGAGGCCATCTTT; Actb: sense 
CAATGAGCTGCGTGTGGC, antisense 
GTACATGGCTGGGGTGTTGA). Each measurement was 
performed in quadruplicate and each experiment in 
triplicate. The expression data were normalized using the 
expression values of Actb gene. Amplification efficiency 
for each primer pair was determined by amplification of 
a linear standard curve (from 0.1 ng to 20 ng) of total 
cDNA as assessed by A260 spectrophotometry. Standard 
curves displayed good linearity and amplification 
efficiency for all primer pairs.  
 
Respiratory response to 6% CO2 enriched air 
mixture 
 
The assessment of the effect of RCF manipulation on CO2 
sensitivity has been conducted measuring the respiratory 
responses to 6% air-CO2 concentration in young (PND 16-
20) and adult (PND 75) H, N-H, RCF and N-RCF animals. 
The changes in tidal volume (i.e., the volume of air 
displaced between normal inspiration and expiration, TV) 
during 6% CO2-enriched air breathing (CO2 challenge) 
were measured in an unrestrained plethysmograph 
(PLY4211, Buxco Electronics, Sharon CT) carrying two 
separate Plexiglas chambers of 450 ml. This allows for 
the parallel assessment of 2 animals/session. Before any 
recording, each subject was closed in its chamber for an 
acclimatization of 40 min. Then, the recording of 
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respiratory parameters started under air condition 
(baseline) for 20 min. Next, the challenge began with the 
administration of 6% CO2 enriched air, followed by a 20 
min recovery period (air). A complete session thus lasted 
80 min per animal. 
 
Statistical analysis 
Maternal behavior. Data were analyzed by two way 
ANOVAs, the factors being (1) manipulation (4 levels: H, 
N-H, RCF and N-RCF); and (2) developmental age (2 levels 
repeated measure:PND2–4 and PND 5–7). The 
observation period was split into 2 time-windows: PND2–
4 (daily cross—fostering period) and PND5–7 (definitive 
adoption for the RCF group) to control for the immediate 
effect of the RCF protocol. 
 
Ultrasonic Vocalizations (PND8). A one-way ANOVA, the 
factor being manipulation (4 levels: H, N-H, RCF and N-
RCF), was used to compare the total number of 
vocalizations emitted by pups during the 5 min of 
isolation session. The sex of the pup was not considered 
as we never observed a male-female difference in 8-day 
old pups’ ultrasonic emission (D’Amato et al. 2011; 
Cinque et al. 2012) 
 
Sociability and social preference. One-way ANOVAs, the 
factor being manipulation (4levels: H, N-H, RCF and N-
RCF), were conducted on a Sociability and Social 
Preference index that measured the percentage of time 
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spent close to unfamiliar partners (Time Close 
unfamiliar/(Total Time close to both cylinders) X 100).  
 
Emotionality. The time spent in the different arms of the 
apparatus was evaluated by automatic software analysis 
(SMART, PanLab) and the percentage of time spent in 
open arms was used as behavioral index of emotionality 
(100 X Time Open/(Time Open +Time Closed) in a one-
way ANOVA, the factor being the postnatal manipulation 
(4 levels: H, N-H, RCF and N-RCF). 
 
HPA axis functionality: corticosterone response to 
novelty. The mean serum corticosterone levels of mice 
were compared by a two-way ANOVA, the factors being 
(1) manipulation (4 levels: H, N-H, RCF and N-RCF); and 
(2) time intervals (3 levels: time 0, 20' and 60'). 
 
Hippocampal mRNA Analyses: GR and MR expression 
(Real-time PCR analysis).Expression data were presented, 
after normalization, as the fold-changes over the 
expression values of control samples (H vs. N-H and RCF 
vs. N-RCF). Independent t-tests between treated and 
control delta Cts (H vs. N-H and RCF vs. N-RCF) were used 
to evaluate significant differences in gene expression. 
 
Respiratory response to 6% CO2 enriched air mixture. A 
one way ANOVA, the factor being early manipulation (4 
levels: H, N-H, RCF and N-RCF), was used to compare the 
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mean percentage of increment of tidal volume from 
baseline (∆TV %) during 6% CO2 exposure. 
 
RESULTS 
This section contains results of the experiment 1 but the 
figures are contained in the paper already published 
(Luchetti et al. 2015) and reported in the appendix A. 
Here there is a summary table of the all results (table1). 
 
Maternal Behavior  
 
The total amount of nursing and grooming behavior 
received by pups exposed to different manipulations is 
shown in Figure 2. The statistical analysis revealed that 
different manipulations did not affect the total amount 
of nursing and grooming/licking received by pups during 
the first week of life (NP: F(3/48)= 1.00, ns; GP/L: F(3/48) 
= 1.67,ns) but, while NURSING decreased during the first 
week of life (F(1/48) = 14.27, p < 0.001), pups’ grooming 
and licking remained relatively stable (F.1=48/ = 1.41, ns) 
across all 4 experimental groups.  
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Figure 2. Maternal care received by pups exposed to different 
post-natal manipulations. Data are presented as mean (+SE) 
group scores for 3-day intervals (PND2–4 and PND5–7). 
Experimental groups: H: Handled; N-H: Non-Handled; RCF: 
Repeated Cross-Fostering; N-RCF: Control. *p < 0.05 
 
The interaction between postnatal manipulation and 
time reached statistical significance only for NURSING 
(NP: F (3/48) = 3.80, p < 0.02; GP/L: F(3/48) = 0.98,ns). H 
pups received more nursing than all others groups, but 
only during PND2–4. The amount of nurturing received 
by both control groups (N-H and N-RCF) was very similar.  
 
 
Ultrasonic Vocalizations  
 
The response to isolation measured in pup on PND8 is 
shown in Figure 3: the ANOVA indicates a significant 
difference between groups (F (3/23) = 4.30, p < 0.05). 
RCF pups emitted the highest number of USVs in 
comparison with all other groups during the 5 min 
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session. Again, the 2 control groups (N-H and N-RCF) 
confirmed similar.  
 
 
Figure 3. Mean (+SE) number of ultrasonic calls (USVs) 
emitted by 8-day old pups of different experimental 
groups,when isolated in their own home-cage bedding for 5 
min. *p < 0.05  
 
 
Sociability and Social Preference 
 
During the habituation session, when young male mice 
explored the 3 compartments cage, no difference in the 
time spent in the different chambers was detected. 
Neither sociability towards unfamiliar partners (F(3/42) = 
0.77,ns), nor social preference (F(3/47) = 1.22,ns) were 
affected by early manipulations (results represented 
respectively in figures 4A and 4B). Considering time spent 
close to cylinders, more than 50% of this time involved 
exploration of the unfamiliar mouse and no 
preference/avoidance of siblings was detected. 
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Figure 4. Sociability and Social Preference scores (mean + SE). 
(A) Sociability (preference for conspeciﬁc vs. object) and (B) 
Social preference (preference for conspeciﬁc vs. littermate) for 
unfamiliar male mouse (same strain, age and treatment) of 
juvenile males tested on PND28 and PND35, respectively. Both 
indices are calculated as the percentage of time spent close to 
unfamiliar partners (Time Close unfamiliar/(Total Time close to 
both cylinders) × 100). 
 
Emotionality 
 
Postnatally handled adult males showed, as expected, 
reduced emotionality in the plus maze test (Figure 5). 
The one-way ANOVA indicated a significant treatment 
effect (F (3/33) = 4.43, p < 0.01) and post-hoc analysis 
showed that the effect was explained by pups exposed to 
H manipulation. Indeed they spent more time in open 
arms than all other groups. 
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Figure 5. Mean (+SE) percent of time spent in the open arms 
of an elevated plus maze by adult male mice exposed to 
different postnatal manipulations. *p < 0.05 
 
HPA Axis Functionality: corticosterone levels after 
novelty exposure  
 
The corticosterone response to a novel situation in the 4 
experimental groups is depicted in Figure 6A. Mice did 
not differ for the amount of time spent in the central 
part of the arena (F(3/45) = 1.72,ns) during novelty 
exposure. All groups showed an increase in serum 
corticosterone at the end of the novelty test (20 min of 
open field) and a successive reduction of hormone levels 
during the 40 min of recovery in the home cage. The two- 
way ANOVA for repeated measures indicated a 
significant time effect (F (2/63) = 31.59, p < 0.001) and no 
experimental group (F (3/63/ = 1.54,ns),or group X time 
(F(6/63) = 0.76,ns) effects. However, subsequent Tukey 
post hoc analysis revealed that the increase in 
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corticosterone at the end of the open field exposure 
(baseline vs. Time 20') was significantly higher in all 
groups but not in the group exposed to handling during 
postnatal life.  
 
 
Figure 6.  (A) Mean (+SE) serum corticosterone levels of male 
mice from different experimental groups before (Time 0), at 
the end of novelty (Time 20 0 ), and 40 min after 
reintroduction in their home cage (Timer 60 0 ). (B) Fold 
changes of hippocampal mRNA for Glucocorticoid (GR) and 
Mineralocorticoid (MR) receptors. * p < 0.05 
 
Hippocampal mRNA Analyses: GR and MR 
Expression 
 
The results of GR and MR gene expression in the 
hippocampal region, evaluated by real time PCR, 
indicated no significant differences between groups, 
either for GR and MR gene expression (Figure 6B). Both 
GR and MR Delta CTs did not differ either between H and 
N-H (t(8) = 0, ns and t(8) = 0, ns, respectively), or 
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between RCF and N-RCF (t(12) = 0.28, ns and t(12) = -
0.79, ns, respectively).  
 
Respiratory Response to CO2-Enriched Environment 
 
Adult male mice responses to 6% CO2-enriched air are 
shown in Figure 7. The physiological increase in TV was 
significantly enhanced in RCF subjects (F (3/30) = 3.64, p 
< 0.05) compared to all other groups. Results regarding 
respiratory response in young animals showed the same 
effects seen in adults. 
 
 
 
Figure 7. Mean (+SE) percentage of Tidal Volume changes 
from baseline ( Δ TV%) for adult male mice from different 
experimental groups, in response to 6% CO2 . * p<0.05 
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BEHAVIOR H  vs  N-
H 
RCF vs N-
RCF 
Maternal behavior received > ns 
USVs response to isolation 
(m+f) 
ns > 
Pups' respiratory Response to 
CO2 (m+f) 
ns > 
Sociability /Social preference 
(m) 
ns/ns ns/ns 
Emotionality in the plus maze 
(m) 
< ns 
Corticosterone response to 
novelty (m) 
< ns 
Hippocampal GR and MR 
expression (m) 
ns ns 
Respiratory Response to CO2 
adulthood (m) 
ns > 
BODY WEIGHT ns ns 
Table 1.Summary table of several behaviors evaluated to 
compare the effects of two different early manipulations: 
handling and repeated cross-fostering. H: handled; N-H: no-
handled; RCF: repeated-cross fostered; N-RCF: no-RCF 
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EXPERIMENT 1. DISCUSSION AND CONCLUSIONS 
Results obtained in this experiment demonstrated that 
the two different early manipulations used, handling and 
repeated cross-fostering, have different and specific 
short- and long- term effects, suggesting that the 
observed phenotypes depend on characteristics and 
timings of early adversities that might activate different 
biological processes.  
These results confirm that repeated daily short 
separation events (Handling) during the first 2 weeks of 
life promote heightened maternal care and are 
associated with reduced behavioral and hormonal 
reactivity to stress (plus maze and restraint stress) in 
adulthood, according to results from many laboratories, 
already reported in the literature (Meaney et al. 1996; 
Schmidt et al. 2003). However differently from previous 
studies in literature, the increased expression of 
hippocampal GRs is no detected in adult H mice (Meaney 
et al. 1985; O’Donnell et al. 1994; Schmidt et al. 2003; 
George et al. 2013).  
On the other hand the RCF procedure, which implies a 
strong interference with the infant-mother attachment 
bond, yielded different and significant effects. Indeed, 
RCF pups did not receive lower amount of maternal care 
compared to controls, but responded to 5 min of 
isolation with a higher amount of distress calls showing a 
separation anxiety response (SAD).  
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Contrary to handling, RCF protocol did not modify 
emotionality (plus maze) and hormonal response 
(corticosterone levels) to stress (Table 1). These results 
are not surprising considering that differences in 
emotionality occurring in H adult animals have been 
explained by the increased levels of maternal care 
received by these animals. Indeed, the increased level of 
grooming/licking behavior received by H pups during the 
first week of life would induce, through epigenetic 
response, changes in brain and behavior persisting until 
adulthood (Champagne et al. 2003).  
Regarding social behaviors the results suggest that 
neither H, nor RCF treatment affected social motivation 
in immature mice. These animals are all interested in 
conspecifics.  
In addition results obtained in this experiment 
demonstrate that, as already reported in previous study, 
RCF animals showed higher, stable and specific 
augmentation of tidal volume in response to 6% CO2-
enriched air mixture (D’Amato et al. 2011). This is 
confirmed here once more, and is specific of RCF subjects 
as it was not seen among H animals. This hypersensitivity 
to CO2 can be turned into a remarkable investigational 
tool and useful endophenotype, allowing modeling PD in 
the mouse. 
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Experiment 2a. Molecular investigations of 
differences in respiratory response to 6% 
CO2 between RCF and control mice 
INTRODUCTION 
 
The first experiment demonstrated that mice exposed to 
RCF paradigm of interference with maternal environment 
and mother-pups bond formation,  showed an enhanced 
separation anxiety and an enhanced hyperventilation in 
response to 6% CO2-enriched air mixture. Also in 
humans, parental instability (early separation or loss) is a 
risk factor for the development of separation anxiety 
disorder (SAD) during childhood and panic disorder 
during adulthood. These two disorders, genetically and 
developmentally-related anxiety disorders, share the CO2 
hypersensitivity endophenotype ( Battaglia et al. 2009) 
and Battaglia demonstrated that early life adversities 
interact with genetic factors to enhance human reactivity 
to hypercapnia condition (Spatola et al. 2011). These 
evidences suggest that the gene-environment interplay 
has  a role in the development of susceptibility to SAD, 
PD and CO2 hypersensitivity as supported by the 
evidences obtained with the RCF model (D’Amato et al. 
2011; Luchetti et al. 2015). The CO2 hypersensitivity 
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associated with early-life adversities can be explained by 
epigenetic mechanisms.  
A molecular basis for hypercapnia-associated respiratory 
diseases has been recently proposed. The amygdala, 
which is known to play a prominent role in fear circuitry, 
has been proved to be a chemosensor for the detection 
of hypercarbia, a function mediated by the acid sensing 
ion channel-1a subunit (ASIC1a). Although asic1a is 
expressed throughout the nervous system, particularly 
high levels are expressed in the amygdala. In rodents, 
CO2 inhalation reduces amygdala pH, inducing acidosis 
and fear behaviors (Ziemann et al. 2009; M. W. Coryell et 
al. 2007; Wemmie et al. 2003). Conversely, disrupting 
asic1a in mice decreases acidosis-induced fear behavior, 
which can be restored through transgenic expression of 
asic1a in the amygdala (Ziemann et al. 2009). However, 
CO2 inhalation was found to induce panic attacks in three 
individuals with bilateral amygdala damage, suggesting 
that amygdala chemosensing is not required for the 
expression of CO2-triggered panic (Feinstein et al. 2013). 
Indeed the acid sensing chemoreceptors have been first 
identified in the brainstem that is an important center of 
breathing regulation (Nattie 1999) and may play a key 
role in CO2 hypersensitivity showed by PD patients and 
RCF animals. 
In addition, several studies exploring the molecular 
genetic of panic disorder suggest that the Human 
ortholog of the rodent acid-sensing ion channel gene, 
ACCN2,  is associated with PD and amygdala structure 
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and function (Gregersen et al. 2012; Smoller et al. 2014) 
Moreover the most comprehensive neuroanatomical 
model of PD has suggested an abnormal sensitivity in the 
brain mechanisms of fear and alarm response involving a 
network of neuronal pathways and multiple 
neurotransmitter systems, including serotonin (5-
hydroxytryptamine, 5-HT), norepinephrine, gamma-
aminobutyric acid (GABA), and others. Accordingly, panic 
attacks originate from a dysfunction in the brain fear 
network that integrates various structures such as the 
brainstem, the amygdala, the hypothalamus, and the 
cortical regions (E Maron, Hettema, and Shlik 2010). 
 
Taken together these considerations and evidences, we 
have conducted a genome-wide investigation of altered 
histone marks (epigenetic investigation) in the 
brainstems (medulla oblongata) of RCF mice and their 
controls. Data from this study (submitted) indicate an 
association between RCF procedure and histone marks in 
the brainstem and in particular we found modifications 
correlate with Asic1 gene expression. 
 
Starting from these considerations, to investigate 
biological bases of enhanced response to hypercapnia in 
RCF mice, by RT-PCR I evaluated mRNA expression of 
some candidate genes in animals’ brainstems. 
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MATERIALS AND METHODS 
 
Animals and experimental groups 
NMRI outbred mice (Harlan, Italy) were used in all 
experiments (2a, 2b, 3 and 4). Animals’ housing and 
mating protocol have already been described in 
Experiment 1. 
 
Experimental groups 
As described in experiment 1, animals were manipulated 
according to the RCF protocol.  
A total of two experimental groups resulted from the 
early manipulation: RCF and their controls (RCF and CT). 
Animals were weaned when 28 days old, and then 
separated by sex and left in cage with littermates. A total 
number of 10 RCF and 10 CT litters were used for all 
experiments presented here. 
Animals were used for: 
 replication and confirmation of the data showed 
in experiment 1 concerning the respiratory 
response to 6% CO2 enriched air mixture  (data 
confirmed but not show here) 
 molecular investigations (experiment 2a); 
 evaluation of new pharmacological treatments 
for the CO2 hyperventilation (experiment 2b);  
 assessment of cognitive capabilities of RCF 
animals (experiment 3); 
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 evaluation of heritability of the respiratory 
endophenotype showed by RCF animals 
(experiment 4). 
 
Brainstem mRNA Analyses (Real-time PCR analysis)  
Adult male mice (90 days old, never tested) were 
sacrificed and brains were rapidly removed and placed 
onto an ice-cooled metal plate. Brainstems were 
dissected and samples were immediately frozen on dry 
ice and stored at −80◦C. RNA was extracted from 
homogenized brainstems (N = 4/5 for each experimental 
group) using a Total RNA purification kit (Norgen Biotek, 
Thorold, ON, Canada) following the instructions of 
manufacturer. RNA quantity was determined by 
absorbance at 260 nm using a NanoDrop UV-VIS 
spectrophotometer (Thermo Fisher Scientific, 
Wilmington, DE, USA). RNA was reverse-transcribed with 
a High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystem, Paisley, UK) according to the manufacturer’s 
instructions. Equal amounts of cDNA were then 
subjected to real-time PCR analysis with an Applied 
Biosystems7900HT thermal cycler, using the 
SensiMixSYBR Kit (Bioline, London, UK) and specific 
primers, listed in table 2, each at a final concentration of 
200 nM. Each measurement was performed in 
quadruplicate and each experiment in triplicate. The 
expression data were normalized using the expression 
values of Actb gene. Amplification efficiency for each 
primer pair was determined by amplification of a linear 
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standard curve (from 0.1 ng to 20 ng) of total cDNA as 
assessed by A260 spectrophotometry. Standard curves 
displayed good linearity and amplification efficiency for 
all primer pairs. Genes selected by our preliminary 
epigenic data and by reports from the  literature (E 
Maron, Hettema, and Shlik 2010; Gregersen et al. 2012) 
are involved in gabaergic transmission (dbi and Gabrd); in 
glutamatergic transmission (grik5); or codify for acid-
sensing ionic channels (asic1), solute carriers (slc17a7, 
slc6a13, slc6a4), glycine receptor (gla3), pleiotrophin 
(ptn), phospholipase C (plcg2), and prostaglandin 
synthase (ptgds). 
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PRIMER SENSE ANTISENSE 
DBI 
 
GGACTCGTGGAACAAGCTGA TCCACATAGGTCTTCATGGCAC 
ASIC1 
 
TTTGTGTCTTGCCAGGAGCAG TGGTAACAGCATTGCAGGTG 
GABRD 
 
ACGGAAAGCCAAGGTCAAGG GACGATGGCGTTCCTCACAT 
GLA3 TGGGCATCACCACTGTACTT CACAAAAAGGAGGCACACCG 
GRIK5 GGCGGTCATGGAGTTCATCTG TCTCCTGGCACACCGACAC 
PLCG2 AGTGAAGACATCGAGCTGGC CAGTTGGCGACAGGAGGAAT 
PTGDS CCACCTTTAGCAAGGCCCAG CTGACTTCTCTCACCTGCGT 
PTN AAAACTGTCACCATCTCCAAGC TCTCCTGTTTCTTGCCTTCCTTT 
SLC17A7 CCATCATCGTGGGTGCAATG TAGTGCACCAGGGAGGCTAT 
SLC6A13 TGTTGGCTCTTTTTCACGCC GTGGCGTGTATTTGATCAGGG 
SLC6A4 CTGATCAGCACTCCAGGGAC GGATGTCCCCACACGGAAT 
Table 2. List of genes and related primers used for the analysis 
of mRNA expression in animals’ brainstems. 
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Statistical analysis 
Expression data are shown, after normalization, as fold-
changes over the expression values of control samples.  
Non-parametric tests (Mann-Whitney) between treated 
and control delta Cts (RCF vs. CT) were used to evaluate 
significant differences in gene expression between 
groups. 
RESULTS 
 
Brainstem mRNA Analyses (Real-time PCR analysis)  
The non-parametric statistics used to compare small 
samples (Mann-Whitney U test) indicates a significant 
difference in mRNA between RCF (n = 5) and CONT (n = 
4) for the expression of Asic1 (p= 0.05), Dbi (p=0.02), 
Gla3 (p= 0.05), Ptn (p= 0.02), Grik5 (p= 0.05), Plcg2 (p= 
0.05), Gabrd (p= 0.05), Ptn (p= 0.05) and Slc17a7 (p= 
0.05) genes (Figure 8A and 8B).  
Figure 8A shows the comparison between RCF and CONT 
ΔCt defined by RT-PCR. The Ct (cycle threshold) is defined 
as the number of cycles required for the fluorescent 
signal to cross the threshold (i.e. exceeds background 
level). Ct levels are inversely proportional to the amount 
of target nucleic acid in the sample (i.e. lower Ct level 
means a greater amount of target nucleic acid in the  
sample).  Figure 8B shows the fold-changes of RCF over 
the expression values of control samples. 
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Figure 8A.Gene expression in animals’ brainstems presented, 
after normalization, as ΔCt comparing RCF and CT animals. 
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Figure 8B.Gene expression in animals’ brainstems presented, 
after normalization, as fold-changes of RCF over the expression 
values of control samples.  
 
EXPERIMENT 2a. DISCUSSION AND CONCLUSIONS 
Results obtained in the experiment 2a demonstrate that 
RCF procedure is able to induce significant differences in 
the mRNA expression of genes suggested to be involved 
in panic disorder, as previously reported in literature 
(Maron et al. 2010). In particular RCF animals showed, in 
brainstem, an increment in the mRNA expression of 
Asic1, Dbi, Gla3 and Ptn genes. Among the others, the 
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results concerning Asic1 and Dbi genes are the most 
interesting.  
Asic1, is a gene which codifies for acid-sensing ion 
channels, has already been related to CO2 
hypersensitivity and fear responses showed by PD 
patients (Coryell et al. 2007; Ziemann et al. 2009; 
Wemmie et al. 2003). The reported increment in Asic1 
gene mRNA in RCF animals supports the hypothesis of a 
central role of acid-base balancing mechanisms in the 
development in panic disorder and also supports the 
validity of the RCF protocol to model PD in animals.  
An increase in Dbi expression, which codifies for 
diazepam binding inhibitor, suggested an alteration in 
GABAergic transmission in RCF animals corroborating the 
hypothesis of an important role of GABAergic 
neurotransmission in the origin of PD as described in the 
literature (Maron et al. 2010). 
These data obtained by RT PCR well correlate with results 
obtained analyzing epigenetic marks in the brainstems of 
these animals. Indeed these latter data (Cittaro et al., 
submitted) demonstrated epigenetic alterations, related 
to gene activation, on the same genes analyzed in RT PCR 
and in particular the alterations were the acetylation of 
Histone 3 (H3Ac) and the tri-methylation of lysine 4 of 
Histone 3 (H3K4me3).  Taken together these data suggest 
that RCF is able to induce epigenetic modifications in 
several genes. 
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Experiment 2b. New pharmacological 
rescue treatments for respiratory 
hypersensitivity to CO2 in a mouse model of 
PD 
INTRODUCTION 
Compounds with reported effectiveness in the treatment 
of PD include tricyclic antidepressants, benzodiazepines, 
serotonin selective reuptake inhibitors (SSRIs), serotonin 
and noradrenaline reuptake inhibitors (SNRIs) and others 
(Freire et al. 2011). Several studies have demonstrated 
that symptoms associated with PAs in PD, and 
laboratory-induced PAs can be rapidly treated with 
benzodiazepines (Tesar and Rosenbaum 1986; Ballenger 
et al. 1988) that enhance inhibitory GABAergic tone and 
represent a fast-acting panicolytic treatment (Baldwin 
2005; Borwin Bandelow et al. 2008; Cloos and Ferreira 
2009). Indeed most evidence suggests that there is a 
reduced inhibitory GABAergic tone in patients with PD as 
indicated by the reduced GABAA R binding in prefrontal 
cortex (Nikolaus et al 2010) or deficits in central GABA 
concentration (Goddard, Mason, et al. 2001). For these 
reasons benzodiazepines are effective but their use 
presents some side effects: for instance routine usage 
makes the drug less effective due to desensitization, and 
there are many side effects such as sedation and 
addiction (Johnson, Federici, and Shekhar 2014). On the 
other hand, some evidences suggest that panic attacks 
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associated with PD can also be treated with slower-acting 
pharmacological therapies that enhance monoaminergic 
(e.g., serotonin, norepinephrine, epinephrine, dopamine, 
and histamine) activity globally [using tricyclic 
antidepressants (Ballenger et al. 1988; Bakker, van 
Balkom, and Spinhoven 2002; Giampaolo Perna, 
Guerriero, and Caldirola 2011) or monoamine oxidase 
inhibitors (MAOI) (Kelly, Mitchell-Heggs, and Sherman 
1971)], or by specifically targeting serotonergic or 
noradrenergic systems with reuptake inhibitors (Cloos 
and Ferreira 2009). Also these treatments exhibit some 
side effects. The use of MAOIs requires a tyramine-
restricted diet and can produce hypertensive crisis. In 
some cases, TCAs and also SSRIs and NRIs increase 
anxiety initially, and begin to show anxiolytic and 
panicolytic properties after 2–3 weeks of daily treatment. 
Thus, the mechanisms by which these compounds are 
panicolytic are through compensatory changes that occur 
with repeated use, and a therapeutic option is to initially 
co-administer a low dose of a benzodiazepine with SSRIs 
to PD patients, which has been shown to result in a 41% 
response rate, compared to 4% response rate for placebo 
+ SSRI group in the first week of treatment (Goddard, 
Brouette, et al. 2001). Resuming effective anti-panic 
medications exist but a substantial proportion of patients 
do not fully respond, the available drugs have several 
side effects and most medications have a delayed onset 
of their therapeutic effect. Thus, further advances are 
needed. 
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To date, the pharmacological research on PD appears to 
be relatively limited and many reasons may explain these 
difficulties, including the heterogeneity of the disorder, 
the incomplete understanding of its underlying 
pathophysiological mechanisms and difficulties in the 
selection of appropriate animal models in preclinical 
studies. Defining biomarkers and endophenotypes in PD 
may offer advantages in both understanding the 
pathophysiology of the disorder and selecting 
appropriate targets and outcomes for planning future 
pharmacological research (Perna, Guerriero, and 
Caldirola 2011). 
 
The experiment 1 demonstrated that RCF manipulation 
lead to develop CO2 hypersensitivity typical of PD 
patients and this abnormal physiological response is a 
useful endophenotype studying PD and possible new 
rescue treatments. In addition the experiment 2a 
showed a possible biological basis responsible for this 
endophenotype: the acid-sensing ion channels (ASIC) 
which could be a target for new pharmacological 
treatments. 
For these reasons in the following experiment three 
different treatments will be evaluated. 
The first group of animals will be treated with a 
benzodiazepine, chlordiazepoxide (CDP), to evaluate 
whether this treatment, commonly used in anxiety and 
panic disorders, is effective in reducing the respiratory 
endophenotype of the RCF mice and thus confirming the 
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validity of this animal model for panic disorder. In 
addition, CDP could restore the normal level of 
transmission, also thanks to decrease levels of DBI 
(inhibitor of GABAergic transmission) which, as reported 
in the previous experiment, is enhanced in RCF mice.  
The second drug used is the chlorogenic acid (CGA), a 
polyphenol contained in green coffee and in some 
vegetables, which has also anxiolytic and antioxidant 
effects (Bouayed et al. 2007; Hassan et al. 2014). CGA is 
able to inhibit the functional activity of ASICs decreasing 
the peak amplitude of proton-gated currents and 
acidosis-evoked membrane excitability (Qu et al. 2014; 
Baron and Lingueglia 2015). In addition CGA, like some 
cathecol-containing dietary polyphenols, is able to inhibit 
DNA methylation through a non-competitive mechanism 
(W. J. Lee and Zhu 2006). CGA could be a reliable new 
pharmacological approach for panic disorder. 
The third treatment will be based on amiloride, a 
previously widely used K+-sparing diuretic agent that is a 
nonselective blocker of ENaC. As the member of ENaC 
superfamily, all ASICs are inhibited by amiloride (Chu et 
al. 2011; Diochot et al. 2007; Lin, Sun, and Chen 2015). In 
general, micromolar concentrations of amiloride inhibit 
ASIC currents in a concentration-dependent manner. 
Data from the literature demonstrated that amiloride 
decreased ASIC-mediated increases in intracellular Ca2+, 
and attenuate acid-induced membrane depolarization 
(Xiong et al. 2004; Yermolaieva et al. 2004; Wu et al. 
2004; Vukicevic and Kellenberger 2004). For its capability 
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to inhibit ASICs also the amiloride could be a promising 
new pharmacological treatment for PD. 
MATERIALS AND METHODS 
 
Animal experimental groups 
Adult males and females NMRI outbred mice were used 
for this experiment. Animals were subjected to early 
repeated cross fostering or control manipulations at 
birth, as described in previous experiments. 
From weaning to post-natal day 60-75 (the day of tests) 
RCF and CT animals were housed in group of four same 
sex/litter in transparent high temperature polysufone 
cages (26.7 × 20.7 × 14.0 cm) with water and food 
available ad libitum, in the animal facility. Room 
temperature (21 ± 1 ◦C) and a 12:12 h light dark cycle 
(lights on at 07.00 p.m.) were kept constant.  
In this experiment we evaluated the acute effects of 
three pharmacological treatments, described in the 
introduction, on the respiratory endophenotype during 
exposure to 6% CO2.  
RCF and CT adult animals were divided in four groups, 
according to the acute treatment: animals treated with 
chlordiazepoxide (CDP), chlorogenic acid (CGA), 
amiloride (AMI) and saline (SAL). CGA and CDP was 
administrated by intraperitoneal injection whereas AMI 
via intranasal administration because it poorly pass the 
blood brain barrier (Miller et al. 2015; Baron and 
Lingueglia 2015). SAL was administrated both 
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intraperitoneally and by intranasal way depending on 
whether it was the control for CGA/CDP or AMI. 
Amiloride treatment was a preliminary experiment so 
until now is made only in female mice. 
 
Effect of different pharmacological treatments on 
the respiratory response to 6% CO2 enriched air 
mixture 
To evaluate the effects of different drugs 
(chlordiazepoxide, chlorogenic acid and amiloride) on the 
respiratory response to 6% CO2 enriched air mixture RCF 
and CT adult animals were tested in the plethysmograph 
apparatus as described above. Unlike the procedure 
already described at the end of the baseline period the 
animals were treated with chlordiazepoxide (5 mg/kg) or 
chlorogenic acid (20 mg/Kg) or amiloride (10 mg/kg) or 
saline depending on the experimental group. The 
treatment was administrated by intra-peritoneal 
injection for CDP and CGA and by intranasal way for AMI. 
After the drug administration the animal returned in the 
plethysmograph chamber and the challenge period (6% 
CO2 enriched air mixture) of twenty minutes started. At 
the end of the challenge period there was a 20 minutes 
of recovery period (normal air). 
Experimental groups for male mice were: RCF SAL (n=7); 
RCF CGA (n=7); RCF CDP (n=6); CT SAL (n=6); CT CGA 
(n=5); CT CDP (n=6). 
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On the other hand experimental groups for female mice 
were RCF SAL (n=6); RCF CGA (n=8); RCF CDP (n=8); CT 
SAL (n=5); CT CGA (n=7) and CT CDP (n=9). In addition for 
females there were the experimental groups for 
amiloride treatment: RCF SAL (n=4), RCF AMI (n=5), CT 
SAL (n=5) and CT AMI (n=4). These were very small 
groups because of the preliminary nature of this 
experimental treatment. 
 
Statistical analysis 
A two way ANOVA, the factors being early manipulation 
(2 levels: RCF and CT) and pharmacological treatments (2 
levels: CDP and SAL or CGA and SAL or AMI and SAL), was 
used to compare the mean percentage of increment of 
tidal volume from baseline (∆TV %) during 6% CO2 
exposure after pharmacological treatment. Males and 
females were considered in different statistical analysis 
 
 
 
 
 
 
 
95 
 
RESULTS 
 
Effect of different pharmacological treatments on 
the respiratory response to 6% CO2 enriched air 
mixture in adult male mice 
Figure 9 (A-B) shows the effect of pharmacological 
treatments on the response to hypercapnia in adult (PND 
75-90) male mice. Regarding the treatment with CGA 
(figure 3A) the ANOVA revealed significant interaction 
between early manipulation and pharmacological 
treatment (F (1/21) = 5.44, p = 0.29). Tukey post-hoc 
analysis revealed significant difference between RCF SAL 
and CT SAL mice (p=0.04) and between RCF SAL and RCF 
CGA animals (p=0.05) suggesting an effect of CGA in 
restoring the normal respiratory response in RCF animals. 
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Figure 9. Effect of pharmacological treatment with CGA (A) and 
CDP (B) on the mean of increment of tidal volume, in response 
to hypercapnic condition (6% CO2), in male adult mice. SAL is 
the control treatment. *p<0.05; **p<0.01 
 
For the treatment with CDP (figure 3B) ANOVA revealed 
a significant effect of the early manipulation (F (1/21) = 
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5.16, p = 0.03) and a significant effect of pharmacological 
treatment (F (1/21) = 11.29, p= 0.003). RCF SAL animals 
showed a significant enhanced respiratory response in 
comparison to all other groups. RCF treated with CPD 
recovered the normal respiratory response as CT 
animals. 
 
Effect of different pharmacological treatments on 
the respiratory response to 6% CO2 enriched air 
mixture in adult female mice 
The Figure 10 (A-B) shows the effect of pharmacological 
treatments on the response to hypercapnia in adult (PND 
75-90) female mice. The ANOVA regarding the treatment 
with chlorogenic acid (CGA, panel A) revealed a 
significant effect of the interaction between neonatal 
manipulation X pharmacological treatments (F (1/22) = 
5.1, p= 0.03). The Tukey post-hoc test revealed statistical 
difference between: RCF SAL animals vs CT SAL animals 
(p= 0.04) and RCF SAL vs RCF CGA (p= 0.02), indeed RCF 
SAL animals showed an enhanced response to 
hypercapnia in comparison with these experimental 
groups. The analysis regarding the treatment with the 
benzodiazepine chlordiazepoxide revealed only the main 
effect of the neonatal treatment (F (1/24) = 6.11, p=0.02) 
but no significance effect of the pharmacological 
treatment. In figure 11 are shown the results regarding 
the effect of the intranasal administration of amiloride 
on the response to hypercapnia in adult (PND 75-90) 
female mice. The ANOVA revealed a significant effect of 
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the neonatal manipulation (F(1/14)= 5.15, p= 0.03), of 
the pharmacological treatment (F(1/114)=14.32, 
p=0,002) and a significant effect of the interaction 
between neonatal treatment X pharmacological 
treatment (F(1/14)= 8.18, p= 0.012).The Tukey post-hoc 
test revealed statistical difference between: RCF SAL 
animals vs CT SAL animals (p= 0.01) , RCF SAL vs RCF AMI 
(p= 0.001) and RCF SAL vs CONT AMI (p= 0.005). 
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Figure 10. Effect of pharmacological treatment with CGA (A) 
and CDP (B) on the mean of increment of tidal volume, in 
response to hypercapnic condition (6% CO2), in female adult 
mice. SAL is the control treatment.*p<0.05 
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Figure 11. Effect of pharmacological treatment with intranasal 
amiloride (10mg/kg), on the mean of increment of tidal volume 
in response to hypercapnia condition (6% CO2), in female adult 
mice. SAL is the control treatment. *p<0.05, **p<0.01 
 
 
EXPERIMENT 2b. DISCUSSION AND CONCLUSIONS 
In the experiment 2b the effects of different 
pharmacological treatments on the respiratory response 
to 6% CO2 in RCF mice was evaluated. On the basis of 
gene expression results in brainstem previously obtained, 
three compounds have been tested: chlordiazepoxide, 
chlorogenic acid and amiloride.  
Specifically, whereas saline treated RCF male mice 
confirmed the enhanced respiratory response to 6% CO2 
enriched air mixture in comparison with controls animals 
(SAL CT), the three drug treatments were able to reduce 
CO2 hypersensitivity in RCF animals. Results 
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demonstrated that both chlordiazepoxide and 
chlorogenic acid are able, in RCF male mice, to restore 
the respiratory response observed in controls.  
Both in female and male mice results confirmed once 
more that the manipulation affects the respiratory 
response to hypercapnic condition, indeed RCF animals 
showed a hyper-ventilatory response to 6% CO2. 
However, unlike males, chlordiazepoxide did not rescue 
RCF female mice respiratory response. Instead RCF 
females treated with chlorogenic acid and amiloride 
recovered the normal respiratory response, suggesting 
that these treatments are more effective than the 
previous one. 
Taken together these results suggest that common drugs 
used currently to treat panic disorder (benzodiazepine) 
could be not always effective, as demonstrated by the 
different responses to chlordiazepoxide shown by male 
and female mice. 
The very interesting theme of these results is that the 
proposed pharmacological treatments acting specifically 
on ASIC channels (chlorogenic acid and amiloride) might 
be effective treatments for panic disorder, considering 
the CO2 hypersensitivity as a useful marker to study this 
disease. Thus these data add further evidence of the 
possible role of ASIC channels in this disorder. In addition 
data concerning the effectiveness of chlorogenic acid are 
very interesting for its role in the inhibition of DNA 
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methylation. Indeed the dosage of this cathecolic 
polyphenol is able to modulate the cellular DNA 
methylation process (W. J. Lee and Zhu 2006). Data 
obtained in experiment 2a demonstrated an enhanced 
expression of ASIC gene related to epigenetic hyper-
methylation of this gene. The therapeutic effect of 
chlorogenic acid reported here could be due to the 
modulation of the methylation process, as well as to its 
role on ASIC current modulation.  
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Experiment 3. Assessment of cognitive 
capability in RCF animals  
 
INTRODUCTION 
Historically, philosophers have subdivided the study of 
the human mind and behavior into two broad categories: 
the cognitive (how we know the world) and the affective 
(how we feel about it). This division is, however, arbitrary 
as cognition — a highly complex construct— and 
emotion interact; cognitive status can color the 
processing of emotions, and changes in mood affect 
cognitive function (Pessoa 2008). It is therefore 
surprising that changes in emotion are universally 
recognized as being inherent to psychiatric disorders and 
their classification, whereas cognitive impairment — 
which has an equally disabling effect on patients — has 
been comparatively neglected. Despite this close 
interrelationship between cognition and mood, the 
cognitive deficits of psychiatric disorders are not just a 
secondary consequence of perturbed affect, and their 
underlying neurobiological substrates differ (Millan et al. 
2012). 
Among distinct psychiatric disorders there are 
contrasting patterns of cognitive deficits. Cognitive 
dysfunction does not just signify poor memory — the 
range of cognitive impairment is broader and more 
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complex. In the case of panic disorder, few studies have 
been published about cognitive dysfunctions; therefore, 
there is still uncertainty as to which cognitive functions 
could be affected by the disorder. The cognitive functions 
expected to be most affected are those related to 
regions involved in the fear network, i.e., the frontal 
cortex and limbic regions in particular. This would 
predominantly involve executive functions and emotional 
processing (Alves et al. 2013). Some studies reported 
that cognitive dysfunction in panic disorders is mainly 
confined to excessive attention and hyper-reactivity to 
threatening, but not emotionally neutral stimuli 
(Castaneda et al. 2008; Gordeev 2008). However, often in 
PD patients an emotionally neutral stimulus, if is present 
during an aversive panic attack, became a threatening 
stimulus able, in turn, to trigger anticipatory anxiety for, 
or an actual occurrence of, panic attacks through classical 
conditioning(Bouton, Mineka, and Barlow 2001). 
Conditioned stimuli contributing to the onset and 
maintenance of panic disorder are thought to extend to 
exteroceptive and interoceptive stimulus events 
resembling those co-occurring with panic (Bouton, 
Mineka, and Barlow 2001; Susan Mineka and Zinbarg 
2006) via stimulus generalization—a learning mechanism 
whereby fear responses extend to a range of stimuli 
resembling the original conditioned stimuli (Pavlov 
1927). For example, conditioned fear to the 
environment/situation where a panic attack occurs might 
transfer, or generalize, to similar environments and 
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situations. Similarly, fear associated with the autonomic 
constituents of panic may generalize to everyday 
activities that elicit similar changes in physiology (e.g., 
exercise or climbing stairs). This conditioned fear 
overgeneralization  could allow an initial panic attack to 
evolve into panic disorder through the proliferation of 
cues that trigger anticipatory anxiety and could be a 
pathogenic marker for panic disorder itself (Lissek et al. 
2010). 
 
Starting from data available from the literature in this 
experiment I investigated the cognitive capability of RCF 
animals. We investigated both the “classical” memory in 
the novel object recognition test and the associative 
learning and retention for conditioning events in two 
different conditions: 1) presentation of general aversive 
stimulus (a foot-shock) in the active avoidance test and 
the 2) presentation of a possible aversive and 
emotionally relevant stimulus (CO2) in a tone fear 
conditioning test. 
 
MATERIALS AND METHODS 
 
Animal experimental groups 
Adult males NMRI outbred mice were used for this 
experiment. Animals were subjected to early repeated 
cross-fostering or control manipulations at birth as 
described in the first experiment. 
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Since weaning until post-natal day 90 (the day of tests) 
RCF and CT mice were housed in group of 4 animals of 
the same sex and litter in transparent high temperature 
polysufone cages (26.7 × 20.7 × 14.0 cm) with water and 
food available ad libitum. Room temperature (21 ± 1 ◦C) 
and a 12:12 h light dark cycle (lights on at 07.00 p.m.) 
were kept constant.  
Males mice were used for the assessment of cognitive 
capability in three different cognitive tests: a) active 
avoidance test; b) object recognition test and c) classical 
conditioning test (tone+CO2). 
 
 
Active avoidance test 
The active avoidance test evaluated associative learning 
and retention for conditioning events (Bovet et al., 1969). 
Briefly, mice learn to avoid a noxious stimulus by a 
specific locomotor response driven by a conditioning 
stimulus which is presented few seconds before the 
noxious stimulus. The apparatus was computer-
controlled and consisted of two sets of eight shuttle 
boxes (acrylic boxes; 40×10 cm) divided into two 20×10 
cm compartments connected by a 3×3 cm opening. A 
light (10 W) was alternately switched on in the two 
compartments and used as conditioned stimulus (CS). 
The CS precedes the onset of the unconditioned stimulus 
(US) by 5 sec, and overlaps it for 25 sec. Using this 
procedure the light is present in the compartment for 30 
sec (5 sec alone and 25 sec together with the US). After 
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30 sec both CS and US are terminated and the cycle 
immediately begin in the other compartment. The US is 
an electric shock (0.2 mA) continuously applied to the 
grid floor (stainless steel rods spaced 0.4 cm apart). Over 
extensive training, mice learn to associate CS and US, and 
to avoid US by running into the dark compartment. An 
avoidance response is recorded when mice avoid US by 
running into the dark compartment within 5 sec of the 
onset of CS. If mice fail to avoid the US they could 
however escape it. In such case, mice responses are 
recorded as simple escape responses. Mice were 
subjected to five daily, 100-trial avoidance sessions. 
Failure of escape response seldom occurred. 
 
Novel object recognition test 
The object recognition task uses the mice's natural 
tendency to explore novel objects and assesses 
recognition memory by measuring its preference for a 
novel object (Ennaceur and Delacour 1988). When the 
mouse shows a preference for the new object (i.e., 
spends more time exploring it) in the presence of a 
familiar object, it can be inferred that the mouse has a 
memory for the familiar object.  
The test took place in an open-field box (58×58×46 cm) 
of Plexiglas with dark floor. The objects used in the task 
varied in shape and color and were made of water-
repellant materials such as plastic.  
The procedure took place in three consecutive days. The 
first day the animals underwent a 5-min habituation 
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period in which time they were free to explore the empty 
arena. On the second day two identical objects were 
placed in arena and each animal was placed at the center 
of the arena and left free for 5 minutes to explore the 
objects. We considered this session as training session.  
After 24 hours from the training session, in the test 
session, two different objects were placed in the box. 
One was a copy of the objects used during the training 
period; the other object was a novel one. A copy of the 
familiar object was used to ensure that the object had 
not been scent-marked during the training period.  
The location of the novel object was counterbalanced, so 
that the novel object was located in the left site of the 
arena for half of the mice and in the right site for the 
other half.  
The box and the objects were cleaned with 10 % ethanol 
solution between trials. 
 
CO2 Fear conditioning paradigm  
Fear conditioning (FC) is the most common model of 
aversive memory in rodents. Main characteristics include 
development of classical conditioning associations with 
emergence of non-associative hyperarousal reactions 
(Sauerhöfer et al. 2012) and generalization of fear to 
situations sharing less common features with the original 
one (Balogh et al.,2002; Winocur et al.,2007). The FC 
paradigm consists in the association of a conditioned 
stimulus (CS: 9,5 kHz tone) with an aversive 
unconditioned stimulus (US). 
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Unlike the classical fear conditioning where the US is a 
foot shock, in this protocol we used as US the exposure 
to CO2 air mixture. We used 6 % CO2 because we 
questioned whether RCF, in comparison with CT animals, 
could be more responsive to the aversive valence of this 
US, and thus more easily conditioned to an associated 
tone. The conditioned behavior evaluated was the 
respiratory profile. 
The procedure consisted in:  
a) animals' exposure to the context for familiarization 
with the plethysmograph apparatus (D1);  
b) pairing of CS with US during the training session (D2) ; 
c) animals' exposure to the CS only during the test 
session (D3) to assess the conditioned behavior. 
During the habituation (D1) the animals were placed in 
plethysmograph chamber two times (11 a.m. and 15 
p.m.) for 10 minutes to familiarize with the context. 
The day after (D2: training session) the animals were 
placed in plethysmograph apparatus. After 10 minutes of 
habituation (baseline measurement of respiratory 
response) a 20 sec tone (9,5 kHz) paired with 3 minutes 
of 6% CO2 enriched air mixture exposure was delivered 
two times with 2 minutes of recovery interval (normal 
air). The test session (D3) consisted of 10 minute of 
baseline condition followed by 5 minute of 9,5 kHz tone 
presentation. 
During both training and test session respiratory 
parameters as tidal volume and breathing frequency 
have been recorded. 
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Statistical analysis 
Active avoidance test 
A repeated measures ANOVA, the factor being early 
manipulation (2 levels: RCF and CT) and daily session as 
repeated measure (from D1 to D5), was used to compare 
the mean percentage of conditioned responses displayed 
by animals. 
 
Novel object recognition test 
A repeated measures ANOVA, the factor being early 
manipulation (2 levels: RCF and CT) and the repeated 
variable being zones of arena (center or periphery), was 
used to compare the mean of time (sec) spent by RCF 
(n=8) and CT (n=8) animals in each zone of the arena 
during the first day of habituation. 
Regarding the day of training (Day 2) a repeated 
measures ANOVA, the factor being early manipulation (2 
levels: RCF and CT) and the repeated variable being zones 
of arena (object on the left, object on the right), was 
used to compare the mean of time (sec) spent by RCF 
and CT animals in each zone of the arena exploring the 
objects. 
Regarding the day of the test (day 3) repeated measures 
ANOVA, the factor being early manipulation (2 levels: 
RCF and CT) and the repeated variable being zones of 
arena (familiar object, new object), was used to compare 
the mean of time (sec) spent by animals in each zone of 
the arena exploring the new and familiar objects. 
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CO2 fear condition paradigm 
In the training session the ventilatory response (TV) to 
administration of 6% CO2 air mixture  combined to 9,5 
kHz tone was analyzed by repeated measures ANOVA 
using as independent factor early manipulation (2 levels: 
RCF and CT) and as repeated variable the five sessions of 
plethysmograph test. A one-way ANOVA was used to 
analyze the presence of conditioned hyperventilation 
(increment of tidal volume) in response to tone only 
during the test using as independent factor early 
manipulation (2 levels: RCF and CT). 
 
RESULTS 
 
Active avoidance test 
In Figure 12 is shown the % of corrected responses 
shown by RCF (n=7) and CT (n=7) animals to avoid the 
shock during the five days of active avoidance test. The 
ANOVA revealed no difference in the mean of 
percentage of conditioned responses in the two 
experimental groups (F (1/48) = 3.61, p = 0.08).  
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Figure 12.Percentage of conditioned responses shown by RCF 
and CT adult animals during active avoidance test.  
 
 
Novel object recognition test 
In the statistical analysis for the first day of habituation 
to a new environment (Figure 13), there is no effect of 
the neonatal manipulation on the permanence time in 
the different zones of the apparatus. Indeed RCF (n=8) 
and CT (n=8) animals spent the same time in the 
periphery and in center of the arena (F (1/14) = 1.0, 
p=0.33). All the animals had a preference for the 
periphery in comparison to the center. 
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Figure 13.Permanence time in each zone of the apparatus 
during 5 minutes of habituation in the novel object recognition 
test. 
 
Data obtained during the training session of the novel 
object recognition test are shown in Figure 14. ANOVA 
revealed no significant effect of the neonatal 
manipulation on the mean percentage of time spent in 
exploring the two object inside the arena (F (1/14) = 0.63, 
p = 0.43). 
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Figure 14. Mean percentage of time spent in exploring the two 
objects inside the arena during the 5 minutes of training 
session of novel object recognition test.  
 
In Figure 15 are shown the results of the test session of 
the novel object recognition test. All animals recognized 
the new object: both RCF and CT mice spent more time 
close to the new object in comparison to the familiar one 
(F(1/14)= 23.9, p= 0.0002). There is no difference 
between the RCF and CT animals in exploration time of 
the two objects (new and familiar) inside the arena 
(F(1/14)=0.24, p=0.6). 
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Figure 15. Mean percentage of time spent in exploring the two 
objects inside the arena during the 5 minutes of test session of 
novel object recognition test.  
 
CO2 Fear conditioning paradigm  
Results of the training session are shown in Figure 16. 
Data revealed that both CT and RCF animals responded 
to CO2 plus tone during the two challenges presented in 
this session. Indeed tidal volume during the challenges 
was higher than during baseline or recovery period (F 
(4/40) = 13.8, p < 0.0001). 
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Figure 16. Tidal volume of RCF and CT animals during training 
session of CO2 fear conditioning paradigm. 
 
The Figure 17, in the right section, shows conditioned 
hyperventilation response to the tone, represented by 
the percentage of increment of tidal volume during 5 
minutes of tone presentation over baseline tidal volume. 
There is an effect of the neonatal manipulation (F (1/13) 
= 6.7, p= 0.02); indeed RCF (n=7) animals showed a 
stronger conditioned hyperventilation in comparison to 
CT (n=8) animals. In the left section of the same figure is 
represented the timeline of respiratory response during 
baseline and tone exposure in test session. 
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Figure 17. On the left is represented the timeline of respiratory 
response during baseline and tone exposure in test session. On 
the left is displayed the mean percentage of Tidal Volume 
changes from baseline (∆TV %) from different experimental 
groups, in response to 5 min tone presentation in CO2 fear 
conditioning paradigm. Experimental groups: RCF: Repeated 
Cross-Fostered Dams; CT: Control Dams. *p < 0.05  
 
EXPERIMENT 3. DISCUSSION AND CONCLUSIONS 
In this experiment I tested the cognitive capability of RCF 
animals in comparison with controls. Indeed, often 
patients with anxiety disorders (including panic) also 
show cognitive deficits (Alves et al. 2013; Castaneda et al. 
2008). In particular it has been suggested that fear 
overgeneralization, caused by deficit in conditioning 
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processes, could allow an initial panic attack to evolve 
into panic disorder (Lissek et al. 2010). 
Both novel object recognition test and active avoidance 
test suggested that RCF animals are able 1) to recognize 
the novelty as controls, 2) learn to avoid the aversive 
stimulus as controls animals, excluding the possibility 
that RCF mice suffered from major cognitive defects. 
In the CO2 fear conditioning test the stimulus is the CO2 
which is an aversive stimulus emotionally relevant for 
RCF animals.  During the training session both RCF and 
control mice showed hyper-ventilatory response to CO2 
plus tone exposure. Instead only RCF animals showed a 
CO2 conditioned respiratory response during the test 
session, when animals were exposed to the tone alone. 
This suggests that in RCF animals, but not in controls, 
CO2 is able to condition the respiratory endophenotype 
as panic attack does in humans, even in absence of real 
dangers. 
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Experiment 4. Trans-generational 
transmission of respiratory endophenotype 
typical of Panic Disorder  
 
INTRODUCTION 
According to twin studies in humans, shared genetic 
determinants appear to be the major underlying cause of 
the developmental continuity of childhood SAD into adult 
PD, and of the association of both disorders with altered 
sensitivity to CO2 (Battaglia et al. 2009; Battaglia et al. 
2008). In addition to genetic determinants, 
environmental risk factors affect the liability to these 
traits, indeed several life events that influence the 
susceptibility to PD also predict heightened CO2 reactivity 
(Ogliari et al. 2010). Thus there is now the evidence that 
genetic and environmental determinants may not simply 
add, but also interact, to influence human responses to 
CO2 (Battaglia and Ogliari 2005).  
Several studies in humans have documented inheritance 
of the effects of early experiences. Indeed stressful 
events can strongly impact an individual’s development, 
physiology and behavior, and are major risk factors for 
mental health disorders later in life and across 
generations (Heim et al. 2008; Perepletchikova and 
Kaufman 2010). For example children of women with 
post-traumatic stress disorder (PTSD), are more often 
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affected by PTSD and have increased susceptibility to a 
lower level of plasma cortisone like their parents (Yehuda 
et al. 2007). As well as some studies support the idea 
that first-degree relatives of PD patients are more 
responsive to the CO2 challenge than control subjects 
and thus to the panic disorder itself (van Beek and Griez 
2000; Giampaolo Perna et al. 1995; Giampaolo Perna et 
al. 1999; W. Coryell 1997).  
Several studies in mice demonstrated that both negative 
and positive early experiences of one generation are 
transmissible to the subsequent generations by 
epigenetic mechanisms (Franklin et al. 2010; Weiss et al. 
2011; Arai et al. 2009). 
In this experiment I evaluated the transmission of the 
respiratory endophenotype, resulting by the early 
repeated cross fostering manipulation in parental 
generation, to the first no-manipulated generation. 
Preliminary studies conducted in my laboratory (not yet 
published) have shown maternal transmission only, of 
the respiratory endophenotype. For this reason in this 
experiment I replicated previous data, mating RCF and CT 
females only, with control males.  
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MATERIALS AND METHODS 
 
Animals 
Animals used in this experiment were the first generation 
(F1) derived from F0 generation. F0 generation had been 
subjected to postnatal repeated cross fostering 
manipulation or control manipulation, as described for 
the first experiment. F0 RCF and CT females were mated 
when they were 12 weeks old. Mating protocol consisted 
in housing 2 females with 1 male in transparent high 
temperature polysufone cages (26.7 × 20.7 × 14.0 cm) 
with water and food available ad libitum. Room 
temperature (21 ± 1 ◦C) and a 12:12 h light dark cycle 
(lights on at 07.00 p.m.) were kept constant. After 15 
days, males were removed and pregnant females were 
isolated, left in clean cages, and inspected twice a day for 
live pups. F1 litters were not manipulated at all, with the 
exception of litters’ culling to 8 pups (4males and 4 
females) on PND1. 
 
Maternal behavior (F0 dams) 
Maternal behavior was observed daily from PND1 to 
PND7 in two daily sessions (12.00–12.30 and 16.00–
16.30) in the facility room. Maternal behavior 
encompassing: (a) NURSING, including the arched-back 
and blanket postures; and (b) GP/L: grooming and licking 
pups was monitored with an instantaneous sampling 
method (1 sample every 2 min), for a total of 16 sampling 
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points/session (Shoji and Kato 2006b). The analyses of 
maternal behaviors were based on the observation of 
NURSING and GP/L on 15 litters of RCF, 16 litters of CT.  
 
F1 Respiratory response to 6% CO2 enriched air 
mixture 
The ventilatory response to 6% air-CO2 concentration in 
twenty days F1 animals was evaluated. The changes in 
tidal volume (i.e., the volume of air displaced between 
normal inspiration and expiration, TV) during 6% CO2-
enriched air breathing (CO2 challenge) were measured in  
unrestrained plethysmograph (PLY4211, Buxco 
Electronics, Sharon CT) as already described in previous 
experiments. Each subject was closed in its chamber for 
an acclimatization of 40 min. Then, the recording of 
respiratory parameters started under air condition 
(baseline) for 20 min. Next, the challenge began with the 
administration of 6% CO2 enriched air, followed by a 20 
min recovery period (air). A complete session thus lasted 
80 min per animal. 
 
Statistical analysis 
Maternal behavior 
Data were analyzed by repeated measures ANOVA, the 
independent factor being mothers’ early manipulation (2 
levels: RCF and CT); and the repeated variable being 
maternal behaviors during early postnatal days (PND2–
7). 
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Respiratory response to 6% CO2 enriched air mixture 
A one-way ANOVA, the factor being mothers’ 
manipulation (2 levels: RCF and CT), was used to 
compare the mean percentage of increment of tidal 
volume from baseline (∆TV %) during 6% CO2 exposure.  
 
RESULTS 
Maternal behavior (F0 dams) 
The analysis of maternal behaviors did not show 
significant differences in maternal care toward the 
offspring between F0-RCF dams and F0-CT dams (Figure 
18). 
 
 
Figure 18. Amount of maternal care (nursing and grooming) 
displayed by F0 RCF and CT dams toward their offspring during 
the first week of pups’ life.  
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F1 Respiratory response to 6% CO2 enriched air 
mixture 
The analysis of respiratory response (tidal volume) to 6% 
CO2 enriched air mixture in F1 generation is shown in 
Figure 19. The physiological increase in TV was 
significantly enhanced among pups (n=11) of RCF dams (F 
(1/17) = 6.51, p= 0.02) compared to pups (n=8) of CT 
dams. 
 
 
Figure 19. Mean percentage of Tidal Volume changes from 
baseline (∆TV %) for young male and female F1 mice from 
different experimental groups, in response to 6% CO2. 
Experimental groups: RCF: Repeated Cross-Fostered Dams; CT: 
Control Dams. *p < 0.05  
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EXPERIMENT 4. DISCUSSION AND CONCLUSIONS 
In this experiment I evaluated the transgenerational 
transmission of the respiratory endophenotype. Pups of 
first generation/not manipulated, born from RCF and 
control dams have been exposed to 6% CO2 and their 
respiratory profile was evaluated. Pups from RCF 
mothers showed the hyperventilatory response similar to 
their manipulated mother in comparison with pups born 
from control mothers. Observing the maternal behavior 
we were not able to find any differences in maternal 
cares displayed by RCF and CT mothers towards their 
offspring. Taken together these results suggest the 
heritability of the respiratory endophenotype (van Beek 
& Griez 2000) maybe trough an epigenetic mechanism 
(Franklin & Mansuy 2010; Weiss et al. 2011). 
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GENERAL DISCUSSIONS AND CONCLUSIONS 
 
First of all, results reported in this study suggest that the 
behavioral and physiological phenotypes observed during 
development and adulthood depend on characteristics 
and timings of early adversities capable of activate 
different biological processes. Reasonably, the response 
of the animal to the early manipulations is different and 
aimed at maximizing individual fitness: the early 
environment could exert its programming role during this 
developmental plastic period, through specific epigenetic 
modifications. Short, even if repeated, separations from 
the mother (Handling protocol) induce habituation to a 
relatively low stressing environment, enhancing the 
capability of the subject to face new stressful situations. 
By contrast, the disruption of the infant attachment bond 
(RCF protocol) is associated to a modification in the 
respiratory response to high CO2 in breathing air, an 
endophenotype these animals share with PD patients. 
 
 The disruption of infant-mother bond in RCF animals 
suggested by the enhanced separation anxiety at 8 days 
age supports the relation between SAD and PD already 
reported in literature (Battaglia et al., 2009). In addition 
the CO2 reactivity showed by these animals represents a 
useful tool to study PD in pre-clinical research. Models of 
PD used in pre-clinical research measure the defensive 
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behaviors showed by the animals in response to a real 
aversive stimulus (as described in chapter III) and not 
spontaneous fear response in the absence of real 
dangerous situation, as in PD. Not being able to interview 
the animal, about its symptoms, such as fear of dying or 
going crazy as in human PD patients, CO2-
hypersensitivity, observed in patients with panic and 
their unaffected relatives, represents a valid 
endophenotype to model this disorder in animals. Thus 
RCF protocol acquires relevance in the field of animal 
model of panic disorder for its capability to induce this 
CO2 hypersensitivity and to measure fear response in 
absence of real dangerous situation differently from 
others animal model of panic disorder.  
 
 Using the RCF protocol in this study I analyzed possible 
molecular mechanisms underlying the CO2 susceptibility 
(exp 2a), evaluated new pharmacological treatments to 
cure the hyperventilation (exp 2b), explored the 
cognitive capabilities of these animals (exp 3) and 
evaluated the transmission of the respiratory 
endophenotype to the subsequent generation (exp 4). 
 
Molecular alterations found in RCF animals (experiment 
2a) supported the involvement of acid-base balance 
dysregulation in development of CO2 hypersensitivity. 
Indeed RCF animals showed a higher expression in ASIC1 
gene that codifies for acid sensing ion channels. These 
channels are sensitive to lower levels of pH being able to 
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detect changes in CO2 concentration in the body and 
adjust the respiratory function to receive enough O2 not 
to compromise biological processes. Molecular 
investigations in addition revealed alterations in 
GABAergic transmission in RCF animals supporting the 
idea of an involvement of this neurotransmitter in the 
development of PD. RCF animals showed an increased 
expression of Dbi, an inhibitor of GABAergic 
transmission. In addition data not presented in this thesis 
(Cittaro et al., submitted) revealed epigenetic regulation 
of these genes expression (Asic1, Dbi and others), 
involved in the respiratory endophenotype showed by 
RCF animals. 
 
These molecular findings suggest that a possible rescue 
treatment for PD patients should consist in reducing CO2 
hypersensitivity. Lowering of this increased respiratory 
response to modest increase in CO2 could reduce the 
negative feeling associated to condition, reducing the 
conditioning potentiality that favor the development of 
panic disorder, after repeated panic attacks. It is well 
known, that panic attacks are able to condition behaviors 
of PD patients. They indeed tend to avoid situations and 
places similar to those where a panic attack previously 
occurred. Similarly RCF animals showed, in experiment 3, 
behavioral conditioning to the situation previously paired 
with CO2 (tone exposure). It should be now explored 
whether RCF animals generalize the conditioned fear, 
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suggesting how an initial panic attack can evolve into 
panic disorder in humans (Lissek et al. 2010). 
 
The use of benzodiazepine such as chlordiazepoxide was 
able to restore the normal respiratory response to CO2 as 
well, giving pharmacological validation to RCF model. 
However, benzodiazepines have several 
contraindications, especially for chronic treatments and 
their sedative effect should also be taken into 
consideration. Even if I only present few data on the 
effects of chlorogenic acid and amiloride on RCF animals, 
I think these results are very interesting and need further 
and deeper evaluation. Both these compounds 
interacted with the pH sensitive channels (Asics) and 
their administration was able to restore the respiratory 
response observed in control animals. In addition 
chlorogenic acid might acts at epigenetic level being able 
to modulate DNA methylation.  It is possible that CGA 
administration leads to a decrease in DNA methylation in 
those genes hyper-methylated in RCF animals (Asic, Dbi 
and so on). The two different levels of action of CGA 
make it a fascinating rescue treatment to be better 
investigated. In addition the use of the polyphenol 
chlorogenic acid is very interesting because it could be 
assumed stably in the diet, avoiding unspecific side 
effects of common pharmacological treatment for PD. 
Future investigations are aimed at investigating the 
effect of a diet enriched in chlorogenic acid on the 
development of CO2 hypersensitivity in vulnerable 
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individuals (RCF animals and PD patients). Not only the 
diet could prevent the development of the 
hyperventilation, it is also possible that the diet could 
reduce the endophenotype itself, at adulthood, without 
severe side effects. The use of the amiloride is very 
interesting for other reasons. Amiloride was given 
intranasally and seems to have, due to the route of 
administration, very immediate effects. This drug could 
represent a “first-aid self-administrable” treatment for 
PD patients perceiving in advance the negative 
sensations of a panic attack. It could be a strategy to help 
these individuals to face unpleasant situations possibly 
eliciting a PA, helping them to improve the quality of 
their life. 
 
Finally RCF model demonstrated a transgenerational 
transmission of the respiratory endophenotype 
(experiment 4) supporting the hypothesis of gene-
enviroment interplay role to predisposition to panic 
disorder (Spatola et al., 2011). The epigenetic 
mechanisms responsible for this trans-generational 
transmission are under investigation as well as possible 
strategies to prevent this phenomenon. 
 
In conclusion, the Repeated Cross-Fostering  protocol  
seems  a  valid mouse model  of  Panic Disorder  in  
humans:  RCF  mice  show  typical  features  of  this  
disorder such as separation anxiety during childhood, 
CO2 hypersensitivity and CO2  conditioned and avoidance 
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behaviors. Acid sensing ion channels are interesting 
molecular markers which can be used as new targets for 
pharmacological treatments and can help to explain 
hyper-responsiveness to CO2   in PD patients as well. 
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